RxNorm Semantic Concepts Index - 142
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "142".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 142000 | hypromellose 0.5 % / phenylephrine 0.12 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142000 | hypromellose 0.5 % / phenylephrine 0.12 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142000 | hypromellose 0.5 % / phenylephrine 0.12 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142001 | hypromellose 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142001 | hypromellose 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142001 | hypromellose 1 % Ophthalmic Solution | Designated preferred name (PT) | NO | |
RxCUI: 142001 | hypromellose 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142001 | hypromellose 1 % Ophthalmic Solution | Full form of descriptor (FN) | NO | |
RxCUI: 142002 | hypromellose 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 142002 | hypromellose 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142002 | hypromellose 0.5 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
RxCUI: 142002 | hypromellose 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 142002 | hypromellose 0.5 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
RxCUI: 142004 | polyvinyl alcohol 1.4 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 142004 | polyvinyl alcohol 1.4 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 142004 | polyvinyl alcohol 1.4 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142004 | polyvinyl alcohol 1.4 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
RxCUI: 142004 | polyvinyl alcohol 1.4 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
RxCUI: 142004 | polyvinyl alcohol 1.4 % Ophthalmic Solution | British preferred term (PTGB) | YES | |
RxCUI: 142004 | polyvinyl alcohol 1.4 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
RxCUI: 142004 | polyvinyl alcohol 1.4 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
RxCUI: 142005 | hydroxyethyl cellulose 0.44 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142005 | hydroxyethyl cellulose 0.44 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142005 | hydroxyethyl cellulose 0.44 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142012 | carbenoxolone sodium 1 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142012 | carbenoxolone sodium 1 % Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142012 | carbenoxolone sodium 1 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142013 | choline salicylate 8.7 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142013 | choline salicylate 8.7 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142013 | choline salicylate 8.7 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142013 | choline salicylate 8.7 % Oral Gel | Designated preferred name (PT) | NO | |
RxCUI: 142013 | choline salicylate 8.7 % Oral Gel | Full form of descriptor (FN) | NO | |
RxCUI: 1420141 | lyral | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 142015 | cod liver oil 11.4 % / zinc oxide 38 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142015 | cod liver oil 11.4 % / zinc oxide 38 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142015 | cod liver oil 11.4 % / zinc oxide 38 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142015 | cod liver oil 11.4 % / zinc oxide 38 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142015 | cod liver oil 11.4 % / zinc oxide 38 % Topical Ointment | Designated preferred name (PT) | NO | |
RxCUI: 142015 | cod liver oil 11.4 % / zinc oxide 38 % Topical Ointment | Full form of descriptor (FN) | NO | |
RxCUI: 142017 | dimethicone 10 % / cetrimide 0.3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142017 | dimethicone 10 % / cetrimide 0.3 % Topical Cream | Designated preferred name (PT) | NO | |
RxCUI: 142017 | dimethicone 10 % / cetrimide 0.3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142017 | dimethicone 10 % / cetrimide 0.3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142017 | dimethicone 10 % / cetrimide 0.3 % Topical Cream | Full form of descriptor (FN) | NO | |
RxCUI: 142019 | dimethicone 20 % / calamine 1.5 % / zinc oxide 7.5 % Topical Cream | Designated preferred name (PT) | NO | |
RxCUI: 142019 | dimethicone 20 % / calamine 1.5 % / zinc oxide 7.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142019 | dimethicone 20 % / calamine 1.5 % / zinc oxide 7.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142019 | dimethicone 20 % / calamine 1.5 % / zinc oxide 7.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142019 | dimethicone 20 % / calamine 1.5 % / zinc oxide 7.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142019 | dimethicone 20 % / calamine 1.5 % / zinc oxide 7.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142019 | dimethicone 20 % / calamine 1.5 % / zinc oxide 7.5 % Topical Cream | Full form of descriptor (FN) | NO | |
RxCUI: 142020 | cetyl dimethicone 5 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142020 | cetyl dimethicone 5 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142020 | cetyl dimethicone 5 % Topical Oil | Designated preferred name (PT) | NO | |
RxCUI: 142020 | cetyl dimethicone 5 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142020 | cetyl dimethicone 5 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142020 | cetyl dimethicone 5 % Topical Oil | Full form of descriptor (FN) | NO | |
RxCUI: 142023 | calamine 209 MG/ML / peanut oil 125 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142024 | hydrocortisone 0.25 % / crotamiton 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142024 | hydrocortisone 0.25 % / crotamiton 10 % Topical Cream | Designated preferred name (PT) | NO | |
RxCUI: 142024 | hydrocortisone 0.25 % / crotamiton 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142024 | hydrocortisone 0.25 % / crotamiton 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142024 | hydrocortisone 0.25 % / crotamiton 10 % Topical Cream | Full form of descriptor (FN) | NO | |
RxCUI: 142025 | chlortetracycline 30 MG/ML / triamcinolone 1 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142028 | coal tar 30 MG/ML / hydrocortisone 2.5 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142029 | coal tar 6 % / lecithin 0.4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142029 | coal tar 6 % / lecithin 0.4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142029 | coal tar 6 % / lecithin 0.4 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142029 | coal tar 6 % / lecithin 0.4 % Topical Cream | Designated preferred name (PT) | NO | |
RxCUI: 142029 | coal tar 6 % / lecithin 0.4 % Topical Cream | Full form of descriptor (FN) | NO | |
RxCUI: 142030 | coal tar 5 % / pine tar 0.05 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142030 | coal tar 5 % / pine tar 0.05 MG/MG Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142030 | coal tar 5 % / pine tar 0.05 MG/MG Topical Gel | Designated preferred name (PT) | NO | |
RxCUI: 142030 | coal tar 5 % / pine tar 0.05 MG/MG Topical Gel | Full form of descriptor (FN) | NO | |
RxCUI: 142033 | polyethylenes 21.9 % / benzalkonium 0.25 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142033 | polyethylenes 21.9 % / benzalkonium 0.25 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142033 | polyethylenes 21.9 % / benzalkonium 0.25 % Topical Gel | Designated preferred name (PT) | NO | |
RxCUI: 142033 | polyethylenes 21.9 % / benzalkonium 0.25 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142033 | polyethylenes 21.9 % / benzalkonium 0.25 % Topical Gel | Full form of descriptor (FN) | NO | |
RxCUI: 142034 | benzoyl peroxide 10 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 142034 | benzoyl peroxide 10 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142034 | benzoyl peroxide 10 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 142035 | salicylic acid 50 % Topical Ointment | Full form of descriptor (FN) | NO | |
RxCUI: 142035 | salicylic acid 50 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142035 | salicylic acid 50 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142035 | salicylic acid 50 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142035 | salicylic acid 50 % Topical Ointment | Designated preferred name (PT) | NO | |
RxCUI: 142036 | podophyllin 20 % / salicylic acid 25 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142036 | podophyllin 20 % / salicylic acid 25 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142036 | podophyllin 20 % / salicylic acid 25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142036 | podophyllin 20 % / salicylic acid 25 % Topical Ointment | Designated preferred name (PT) | NO | |
RxCUI: 142036 | podophyllin 20 % / salicylic acid 25 % Topical Ointment | Full form of descriptor (FN) | NO | |
RxCUI: 142038 | lactic acid 50 MG/ML / urea 200 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142040 | crude coal tar 2.5 % / lecithin 0.3 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142040 | crude coal tar 2.5 % / lecithin 0.3 % Medicated Shampoo | Designated preferred name (PT) | NO | |
RxCUI: 142040 | crude coal tar 2.5 % / lecithin 0.3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142040 | crude coal tar 2.5 % / lecithin 0.3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142040 | crude coal tar 2.5 % / lecithin 0.3 % Medicated Shampoo | Full form of descriptor (FN) | NO | |
RxCUI: 142042 | chlortetracycline 30 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142044 | econazole 0.01 MG/MG Powder Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142045 | undecylenic acid 5 % / zinc undecylenate 20 % Topical Powder | Full form of descriptor (FN) | NO | |
RxCUI: 142045 | undecylenic acid 5 % / zinc undecylenate 20 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142045 | undecylenic acid 5 % / zinc undecylenate 20 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142045 | undecylenic acid 5 % / zinc undecylenate 20 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142045 | undecylenic acid 5 % / zinc undecylenate 20 % Topical Powder | Designated preferred name (PT) | NO | |
RxCUI: 142046 | metroNIDAZOLE 0.75 % Vaginal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 142046 | metroNIDAZOLE 0.75 % Vaginal Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 142046 | metroNIDAZOLE 0.75 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 142046 | metroNIDAZOLE 0.75 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142046 | metroNIDAZOLE 0.75 % Vaginal Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 142046 | metroNIDAZOLE 0.75 % Vaginal Gel | Designated preferred name (PT) | YES | |
RxCUI: 142046 | metroNIDAZOLE 0.75 % Vaginal Gel | Full form of descriptor (FN) | YES | |
RxCUI: 142047 | amorolfine 0.25 % Topical Cream | Designated preferred name (PT) | NO | |
RxCUI: 142047 | amorolfine 0.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142047 | amorolfine 0.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142047 | amorolfine 0.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142047 | amorolfine 0.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142047 | amorolfine 0.25 % Topical Cream | Full form of descriptor (FN) | NO | |
RxCUI: 142049 | carbaryl 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142049 | carbaryl 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142049 | carbaryl 1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142050 | carbaryl 5 MG/ML Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142051 | malathion 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142051 | malathion 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142051 | malathion 1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142051 | malathion 1 % Medicated Shampoo | Designated preferred name (PT) | NO | |
RxCUI: 142051 | malathion 1 % Medicated Shampoo | Full form of descriptor (FN) | NO | |
RxCUI: 142052 | phenothrin 0.2 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142052 | phenothrin 0.2 % Topical Lotion | Designated preferred name (PT) | NO | |
RxCUI: 142052 | phenothrin 0.2 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142052 | phenothrin 0.2 % Topical Lotion | Full form of descriptor (FN) | NO | |
RxCUI: 142054 | allantoin 2 MG/ML / hexachlorophene 5 MG/ML / squalene 30 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142055 | brilliant green 0.005 MG/MG / lactic acid 0.005 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142057 | heparinoids 50 UNT / hyaluronidase 150 UNT per GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142057 | heparinoids 50 UNT / hyaluronidase 150 UNT per GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142057 | heparinoids 50 UNT / hyaluronidase 150 UNT per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142061 | IgG, human subcutaneous 16 % Injectable Solution | Designated preferred name (PT) | NO | |
RxCUI: 142061 | IgG, human subcutaneous 16 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142061 | IgG, human subcutaneous 16 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142061 | IgG, human subcutaneous 16 % Injectable Solution | Full form of descriptor (FN) | NO | |
RxCUI: 142065 | Simeticone 8.4 mg/mL oral drops | Designated preferred name (PT) | NO | |
RxCUI: 142065 | Simeticone 8.4 mg/mL oral drops | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142065 | Simeticone 8.4 mg/mL oral drops | Full form of descriptor (FN) | NO | |
RxCUI: 142065 | Simeticone 8.4 mg/mL oral drops | Full form of descriptor (FN) | NO | |
RxCUI: 142065 | Simeticone 8.4 mg/mL oral drops | Designated preferred name (PT) | NO | |
RxCUI: 142065 | Simeticone 8.4 mg/mL oral drops | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142065 | Simeticone 8.4 mg/mL oral drops | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142069 | antihemophilic factor, porcine 35 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1420735 | diethylcarbamazine citrate 50 MG [Banocide] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 142074 | budesonide 0.25 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142075 | budesonide 0.00025 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142085 | calcium gluconate 2.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 142085 | calcium gluconate 2.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 142085 | calcium gluconate 2.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142085 | calcium gluconate 2.5 % Topical Gel | Designated preferred name (PT) | YES | |
RxCUI: 142085 | calcium gluconate 2.5 % Topical Gel | Full form of descriptor (FN) | YES | |
RxCUI: 142091 | Activated charcoal 5 g oral granules sachet | Designated preferred name (PT) | NO | |
RxCUI: 142091 | Activated charcoal 5 g oral granules sachet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142091 | Activated charcoal 5 g oral granules sachet | Full form of descriptor (FN) | NO | |
RxCUI: 142092 | natamycin 20 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142093 | lypressin 50 MG/ML Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142095 | mesalazine 1 GM Rectal Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142095 | mesalazine 1 GM Rectal Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142095 | mesalazine 1 GM Rectal Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1420957 | Aloe andongensis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1420958 | Aralia cordata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420959 | Cnidium officinale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 142096 | aprotinin Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1420960 | coconut juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420961 | Daemonodrops draco resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420962 | Dendrobium nobile stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420963 | Ferula assa-foetida whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420964 | gellan gum (low acyl) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1420965 | Hydnocarpus kurzii seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420970 | Inga edulis seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420971 | Lindera aggregata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420972 | Liquidambar orientalis resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420973 | Momordica cochinchinensis seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1420974 | Morus australis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420975 | Nelumbo nucifera stamen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420976 | Paeonia veitchii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420977 | Reynoutria japonica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1420977 | Reynoutria japonica whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1420978 | pyritidium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420979 | schorl tourmaline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420980 | Scrophularia ningpoensis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420981 | Senna alata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420982 | Ethyl carbamate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1420982 | Ethyl carbamate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1420982 | Ethyl carbamate | Designated preferred name (PT) | NO | |
RxCUI: 1420982 | Ethyl carbamate | Full form of descriptor (FN) | NO | |
RxCUI: 1420982 | Ethyl carbamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420982 | Ethyl carbamate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1420983 | ethyl ferulate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1420989 | allantoin / diphenhydramine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1420989 | allantoin / diphenhydramine Topical Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1420990 | allantoin / diphenhydramine Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1420990 | allantoin / diphenhydramine Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1420991 | allantoin / diphenhydramine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1420991 | allantoin / diphenhydramine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1420992 | allatoin 0.5 % / diphenhydrAMINE HCl 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1420992 | allatoin 0.5 % / diphenhydrAMINE HCl 2 % Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1420992 | allatoin 0.5 % / diphenhydrAMINE HCl 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1420992 | allatoin 0.5 % / diphenhydrAMINE HCl 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1420992 | allatoin 0.5 % / diphenhydrAMINE HCl 2 % Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1420993 | Allegra Cooling Relief Anti-Itch | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1420994 | allantoin 5 MG/ML / diphenhydramine hydrochloride 20 MG/ML [Allegra Cooling Relief Anti-Itch] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1420994 | allantoin 5 MG/ML / diphenhydramine hydrochloride 20 MG/ML [Allegra Cooling Relief Anti-Itch] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1420995 | allantoin / diphenhydramine Topical Cream [Allegra Cooling Relief Anti-Itch] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1420995 | allantoin / diphenhydramine Topical Cream [Allegra Cooling Relief Anti-Itch] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1420996 | Allegra Cooling Relief Anti-Itch Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1420997 | Allegra Relief Anti-Itch (allantoin 0.5 % / diphenhydrAMINE HCl 2 % ) Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1420997 | Allegra Relief Anti-Itch (allantoin 0.5 % / diphenhydrAMINE HCl 2 % ) Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1420997 | Allegra Relief Anti-Itch (allantoin 0.5 % / diphenhydrAMINE HCl 2 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1420997 | Allegra Relief Anti-Itch (allantoin 0.5 % / diphenhydrAMINE HCl 2 % ) Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1420997 | Allegra Relief Anti-Itch (allantoin 0.5 % / diphenhydrAMINE HCl 2 % ) Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1420998 | amylase 64000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1420999 | protease 57000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421000 | lipase 9000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1421001 | lipase 9,000 UNT / amylase 64,000 UNT / protease 57,000 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421001 | lipase 9,000 UNT / amylase 64,000 UNT / protease 57,000 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421001 | lipase 9,000 UNT / amylase 64,000 UNT / protease 57,000 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421001 | lipase 9,000 UNT / amylase 64,000 UNT / protease 57,000 UNT Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421002 | PanaKare | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1421003 | amylase 64000 UNT / lipase 9000 UNT / protease 57000 UNT [PanaKare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421004 | amylase / lipase / protease Oral Tablet [PanaKare] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421005 | PanaKare Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421006 | PanaKare Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421007 | PanaKare Plus 9000 UNT / 64,000 UNT / 57,000 UNT Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421007 | PanaKare Plus 9000 UNT / 64,000 UNT / 57,000 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421007 | PanaKare Plus 9000 UNT / 64,000 UNT / 57,000 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421007 | PanaKare Plus 9000 UNT / 64,000 UNT / 57,000 UNT Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421008 | petrolatum 0.62 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421009 | menthol / petrolatum Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421010 | menthol / petrolatum Paste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1421011 | menthol 0.6 % / petrolatum 62 % Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421011 | menthol 0.6 % / petrolatum 62 % Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421011 | menthol 0.6 % / petrolatum 62 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421012 | Lypsyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1421013 | menthol 0.006 MG/MG / petrolatum 0.62 MG/MG [Lypsyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421014 | menthol / petrolatum Paste [Lypsyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421015 | Lypsyl Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421016 | Lypsyl (menthol 0.6 % / petrolatum 62 % ) Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421016 | Lypsyl (menthol 0.6 % / petrolatum 62 % ) Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421016 | Lypsyl (menthol 0.6 % / petrolatum 62 % ) Paste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421017 | ceftiofur 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421018 | ceftiofur 200 MG/ML Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421018 | ceftiofur 200 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421019 | Excede | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 142102 | ibuprofen 5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142102 | ibuprofen 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142102 | ibuprofen 5 % Topical Spray | Designated preferred name (PT) | NO | |
RxCUI: 142102 | ibuprofen 5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142102 | ibuprofen 5 % Topical Spray | Full form of descriptor (FN) | NO | |
RxCUI: 1421020 | ceftiofur 200 MG/ML [Excede] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421021 | ceftiofur Injectable Suspension [Excede] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421022 | Excede Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421023 | EXCEDE 200 MG/ML Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421023 | EXCEDE 200 MG/ML Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421023 | EXCEDE 200 MG/ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421024 | menthol 3 % / methyl salicylate 0.5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1421024 | menthol 3 % / methyl salicylate 0.5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1421024 | menthol 3 % / methyl salicylate 0.5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421025 | menthol / methyl salicylate Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1421026 | menthol / methyl salicylate Paste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1421027 | menthol 3 % / methyl salicylate 0.5 % Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1421027 | menthol 3 % / methyl salicylate 0.5 % Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1421027 | menthol 3 % / methyl salicylate 0.5 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421028 | ceftiofur Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1421029 | ceftiofur 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142103 | ibuprofen 0.05 MG/MG / menthol 0.03 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421030 | Naxcel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1421031 | ceftiofur 50 MG/ML [Naxcel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421032 | ceftiofur Injectable Solution [Naxcel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421033 | Naxcel Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421034 | Naxcel 50 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421034 | Naxcel 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421034 | Naxcel 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421034 | Naxcel 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421035 | maropitant 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421036 | maropitant Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421037 | maropitant Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1421038 | maropitant 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421039 | maropitant 10 MG/ML [Cerenia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 142104 | norepinephrine 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421040 | maropitant Injectable Solution [Cerenia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421041 | Cerenia Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421042 | maropitant 10 MG/ML Injectable Solution [Cerenia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421042 | maropitant 10 MG/ML Injectable Solution [Cerenia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421042 | maropitant 10 MG/ML Injectable Solution [Cerenia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421051 | ThyroKare | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1421052 | levothyroxine sodium 0.1 MG [ThyroKare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421053 | levothyroxine Oral Tablet [ThyroKare] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421054 | ThyroKare Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421055 | ThyroKare Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421056 | ThyroKare 0.1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421056 | ThyroKare 0.1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421056 | ThyroKare 0.1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421057 | levothyroxine sodium 0.2 MG [ThyroKare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421058 | ThyroKare 0.2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421058 | ThyroKare 0.2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421058 | ThyroKare 0.2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421059 | levothyroxine sodium 0.3 MG [ThyroKare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 142106 | Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 142106 | Product containing precisely tauroselcholic acid (75-Se) 37 kilobecquerel/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 1421060 | ThyroKare 0.3 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421060 | ThyroKare 0.3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421060 | ThyroKare 0.3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421066 | levothyroxine sodium 0.4 MG [ThyroKare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421067 | ThyroKare 0.4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421067 | ThyroKare 0.4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421067 | ThyroKare 0.4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421068 | levothyroxine sodium 0.5 MG [ThyroKare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421069 | ThyroKare 0.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421069 | ThyroKare 0.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421069 | ThyroKare 0.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142107 | Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 142107 | Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 1421070 | levothyroxine sodium 0.6 MG [ThyroKare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421071 | ThyroKare 0.6 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421071 | ThyroKare 0.6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421071 | ThyroKare 0.6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421072 | levothyroxine sodium 0.7 MG [ThyroKare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421073 | ThyroKare 0.7 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421073 | ThyroKare 0.7 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421073 | ThyroKare 0.7 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421074 | levothyroxine sodium 0.8 MG [ThyroKare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421075 | ThyroKare 0.8 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421075 | ThyroKare 0.8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421075 | ThyroKare 0.8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421079 | lactic acid 95 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 142108 | Dithranol 2.5 mg/g and salicylic acid 16 mg/g cutaneous gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142108 | Dithranol 2.5 mg/g and salicylic acid 16 mg/g cutaneous gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142108 | Dithranol 2.5 mg/g and salicylic acid 16 mg/g cutaneous gel | Designated preferred name (PT) | NO | |
RxCUI: 142108 | Dithranol 2.5 mg/g and salicylic acid 16 mg/g cutaneous gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142108 | Dithranol 2.5 mg/g and salicylic acid 16 mg/g cutaneous gel | Full form of descriptor (FN) | NO | |
RxCUI: 1421080 | lactic acid 9.5 % / dodecylbenzenesulfonic acid 1.6 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421080 | lactic acid 9.5 % / dodecylbenzenesulfonic acid 1.6 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421080 | lactic acid 9.5 % / dodecylbenzenesulfonic acid 1.6 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142113 | mesna 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 142113 | mesna 400 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 142113 | mesna 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 142113 | mesna 400 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 142114 | mesna 600 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142114 | mesna 600 MG Oral Tablet | Designated preferred name (PT) | NO | |
RxCUI: 142114 | mesna 600 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142114 | mesna 600 MG Oral Tablet | Full form of descriptor (FN) | NO | |
RxCUI: 1421146 | Pikea robusta extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421147 | bovine bone preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421147 | bovine bone preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421148 | bovine duodenum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421148 | bovine duodenum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421149 | bovine prostate gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421149 | bovine prostate gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142115 | spiramycin 250 MG Oral Tablet | Full form of descriptor (FN) | NO | |
RxCUI: 142115 | spiramycin 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142115 | spiramycin 250 MG Oral Tablet | Designated preferred name (PT) | NO | |
RxCUI: 142115 | spiramycin 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421150 | calcium malate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421151 | gadoterate meglumine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1421158 | 5-Way Calf Scour Bolus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1421159 | oxytetracycline hydrochloride 500 MG [5-Way Calf Scour Bolus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421160 | oxytetracycline Oral Tablet [5-Way Calf Scour Bolus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421161 | 5-Way Calf Scour Bolus Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421162 | 5-Way Calf Scour Bolus Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421163 | 5/Way Calf Scour Bolus 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421163 | 5/Way Calf Scour Bolus 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421163 | 5/Way Calf Scour Bolus 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421164 | Skinmedica Purifying Foaming Wash | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1421165 | salicylic acid 20 MG/ML [Skinmedica Purifying Foaming Wash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421166 | salicylic acid Medicated Liquid Soap [Skinmedica Purifying Foaming Wash] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421167 | Skinmedica Purifying Foaming Wash Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421168 | SkinMedica Purifying 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421168 | SkinMedica Purifying 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421168 | SkinMedica Purifying 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421168 | SkinMedica Purifying 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421169 | Skinmedica Purifying Toner | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1421170 | salicylic acid 20 MG/ML [Skinmedica Purifying Toner] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421171 | salicylic acid Topical Solution [Skinmedica Purifying Toner] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421172 | Skinmedica Purifying Toner Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421173 | SkinMedica Toner 2 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421173 | SkinMedica Toner 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421173 | SkinMedica Toner 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421173 | SkinMedica Toner 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421174 | pasireotide Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1421176 | meglumine iotroxinate Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421177 | cafedrine / theodrenaline Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421178 | calcium glubionate Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421179 | raltegravir Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 1421179 | raltegravir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1421179 | raltegravir Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 142118 | SMX 100 MG / TMP 20 MG Oral Tablet | Full form of descriptor (FN) | NO | |
RxCUI: 142118 | SMX 100 MG / TMP 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142118 | SMX 100 MG / TMP 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142118 | SMX 100 MG / TMP 20 MG Oral Tablet | Designated preferred name (PT) | NO | |
RxCUI: 1421180 | pradofloxacin Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421181 | azosemide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421182 | calcium carbonate / calcium glubionate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421183 | calcium glubionate Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421184 | thyroid, porcine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421185 | raltegravir Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1421186 | calcium glubionate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421187 | Sorghum bicolor pollen extract Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421188 | calcium glubionate / calcium lactobionate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421188 | calcium glubionate / calcium lactobionate Oral Product | Designated preferred name (PT) | NO | |
RxCUI: 1421188 | calcium glubionate / calcium lactobionate Oral Product | Full form of descriptor (FN) | NO | |
RxCUI: 1421189 | calcium glubionate / calcium lactobionate Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421191 | omacetaxine mepesuccinate Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1421191 | omacetaxine mepesuccinate Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 1421191 | omacetaxine mepesuccinate Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 1421192 | isoflupredone Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421193 | pradofloxacin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421194 | calcium carbonate / calcium glubionate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421195 | raltegravir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1421197 | thyroid, porcine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421198 | racecadotril Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421199 | cicletanine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 142120 | estradiol 1 MG Oral Tablet [Climaval] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142120 | estradiol 1 MG Oral Tablet [Climaval] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421200 | azosemide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421201 | cicletanine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421202 | 2-mercaptobenzothiazole Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421203 | Candida albicans allergenic extract Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1421204 | ceruletide diethylamine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421205 | racecadotril Oral Product | Full form of descriptor (FN) | NO | |
RxCUI: 1421205 | racecadotril Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421205 | racecadotril Oral Product | Designated preferred name (PT) | NO | |
RxCUI: 1421206 | cafedrine / theodrenaline Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421208 | cafedrine / theodrenaline Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 142121 | sodium fluoride 1.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421211 | KOPERTOX Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 142125 | levOCARNitine 300 MG/ML Oral Solution | Designated preferred name (PT) | NO | |
RxCUI: 142125 | levOCARNitine 300 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142125 | levOCARNitine 300 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 142125 | levOCARNitine 300 MG/ML Oral Solution | Full form of descriptor (FN) | NO | |
RxCUI: 142129 | Floxapen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 142130 | Acebutolol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142130 | Acebutolol hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142130 | Acebutolol hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 142131 | Magnesium aspartate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 142131 | Magnesium aspartate | Designated preferred name (PT) | YES | |
RxCUI: 142131 | Magnesium aspartate | Full form of descriptor (FN) | YES | |
RxCUI: 142131 | Magnesium aspartate | Designated preferred name (PT) | YES | |
RxCUI: 142131 | Magnesium aspartate | Full form of descriptor (FN) | YES | |
RxCUI: 142132 | Carteolol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142132 | Carteolol hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142132 | Carteolol hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 142133 | Dosulepin hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142133 | Dosulepin hydrochloride | Full form of descriptor (FN) | NO | |
RxCUI: 142133 | Dosulepin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 142133 | Dosulepin hydrochloride | Designated preferred name (PT) | NO | |
RxCUI: 142135 | Fosfomycin tromethamine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142135 | Fosfomycin tromethamine | Designated preferred name (PT) | YES | |
RxCUI: 142135 | Fosfomycin tromethamine | Full form of descriptor (FN) | YES | |
RxCUI: 142136 | Histamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142136 | Histamine hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142136 | Histamine hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 142136 | Histamine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142138 | Mexiletine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142138 | Mexiletine hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142138 | Mexiletine hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 142141 | aminobenzoate potassium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142141 | aminobenzoate potassium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 142141 | aminobenzoate potassium | Designated preferred name (PT) | NO | |
RxCUI: 142141 | aminobenzoate potassium | Full form of descriptor (FN) | NO | |
RxCUI: 142141 | aminobenzoate potassium | Designated preferred name (PT) | NO | |
RxCUI: 142141 | aminobenzoate potassium | Full form of descriptor (FN) | NO | |
RxCUI: 1421429 | Adansonia digitata seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 142143 | viloxazine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142143 | viloxazine hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142143 | viloxazine hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 1421430 | salmon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421431 | tridecyl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421432 | Barleria prionitis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421433 | Cajanius cajan leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421434 | coco diisopropanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1421435 | Crinum asiaticum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421436 | Zingiber moutanum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421437 | PPG-2 hydroxyethyl cocamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1421438 | Pacific cod preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 142144 | Betaxolol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142144 | Betaxolol hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142144 | Betaxolol hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 1421440 | menthol 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421441 | menthol 15 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421441 | menthol 15 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421442 | menthol 15 MG [Halls] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421443 | Halls 15 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421443 | Halls 15 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421443 | Halls 15 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421444 | etilevodopa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421445 | casein, Streptococcus thermophilus cultured, Propionibacterium freudenreichii subsp. shermanii cultured, aged preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421446 | Piper betle leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421448 | brimonidine / brinzolamide Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1421449 | brimonidine / brinzolamide Ophthalmic Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 142145 | Tocainide hydrochloride | Designated preferred name (PT) | NO | |
RxCUI: 142145 | Tocainide hydrochloride | Full form of descriptor (FN) | NO | |
RxCUI: 142145 | Tocainide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1421450 | brimonidine / brinzolamide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1421451 | brinzolamide 1 % / brimonidine tartrate 0.2 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421451 | brinzolamide 1 % / brimonidine tartrate 0.2 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1421451 | brinzolamide 1 % / brimonidine tartrate 0.2 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1421452 | Simbrinza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1421453 | brimonidine tartrate 2 MG/ML / brinzolamide 10 MG/ML [Simbrinza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1421454 | brimonidine / brinzolamide Ophthalmic Suspension [Simbrinza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1421455 | Simbrinza Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1421456 | SIMBRINZA 1 % / 0.2 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1421456 | SIMBRINZA 1 % / 0.2 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421456 | SIMBRINZA 1 % / 0.2 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1421458 | ethinyl estradiol / norethindrone Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1421459 | ethinyl estradiol 20 MCG / norethindrone acetate 1 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1421459 | ethinyl estradiol 20 MCG / norethindrone acetate 1 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 142146 | Bisoprolol fumarate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142146 | Bisoprolol fumarate | Designated preferred name (PT) | YES | |
RxCUI: 142146 | Bisoprolol fumarate | Full form of descriptor (FN) | YES | |
RxCUI: 1421460 | ferrous fumarate 75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1421460 | ferrous fumarate 75 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1421461 | Eth estra-Noreth Ac 0.02-1 MG (24) Oral Capsule / Ferr fum 75 MG (4) Oral Capsule 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 1421461 | Eth estra-Noreth Ac 0.02-1 MG (24) Oral Capsule / Ferr fum 75 MG (4) Oral Capsule 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1421461 | Eth estra-Noreth Ac 0.02-1 MG (24) Oral Capsule / Ferr fum 75 MG (4) Oral Capsule 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421462 | Minastrin 24 Fe 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
RxCUI: 1421462 | Minastrin 24 Fe 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421465 | cysteamine 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1421466 | cysteamine Delayed Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1421467 | cysteamine 25 MG Delayed Release Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 1421467 | cysteamine 25 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421467 | cysteamine 25 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1421467 | cysteamine 25 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1421467 | cysteamine 25 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421467 | cysteamine 25 MG Delayed Release Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 1421468 | Procysbi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1421469 | cysteamine 25 MG [Procysbi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1421470 | cysteamine Delayed Release Oral Capsule [Procysbi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1421471 | Procysbi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1421472 | Procysbi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1421473 | PROCYSBI 25 MG Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1421473 | PROCYSBI 25 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421473 | PROCYSBI 25 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1421473 | PROCYSBI 25 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421474 | cysteamine 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1421475 | cysteamine 75 MG Delayed Release Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 1421475 | cysteamine 75 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421475 | cysteamine 75 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1421475 | cysteamine 75 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1421475 | cysteamine 75 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421475 | cysteamine 75 MG Delayed Release Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 1421476 | cysteamine 75 MG [Procysbi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1421477 | PROCYSBI 75 MG Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1421477 | PROCYSBI 75 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421477 | PROCYSBI 75 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1421477 | PROCYSBI 75 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421478 | Limulus polyphemus extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 142149 | Granisetron hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142149 | Granisetron hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142149 | Granisetron hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 142150 | Lymphocyte antigen CD42d | Designated preferred name (PT) | NO | |
RxCUI: 142150 | Lymphocyte antigen CD42d | Full form of descriptor (FN) | NO | |
RxCUI: 142152 | Delavirdine mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142152 | Delavirdine mesilate | Full form of descriptor (FN) | YES | |
RxCUI: 142152 | Delavirdine mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142152 | Delavirdine mesilate | Designated preferred name (PT) | YES | |
RxCUI: 142153 | Salbutamol sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142153 | Salbutamol sulfate | Designated preferred name (PT) | YES | |
RxCUI: 142153 | Salbutamol sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142153 | Salbutamol sulfate | Full form of descriptor (FN) | YES | |
RxCUI: 1421547 | PEG-9 diglycidyl ether and sodium hyaluronate cross polymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1421548 | Booty Goo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1421549 | zinc oxide 0.25 MG/MG [Booty Goo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421550 | zinc oxide Topical Ointment [Booty Goo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421551 | Booty Goo Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421552 | Booty Goo 25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421552 | Booty Goo 25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421552 | Booty Goo 25 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421552 | Booty Goo 25 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421552 | Booty Goo 25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421555 | dextromethorphan HBr 10 MG / guaifenesin 100 MG / phenylpropanolamine HCl 12.5 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421555 | dextromethorphan HBr 10 MG / guaifenesin 100 MG / phenylpropanolamine HCl 12.5 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421555 | dextromethorphan HBr 10 MG / guaifenesin 100 MG / phenylpropanolamine HCl 12.5 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421555 | dextromethorphan HBr 10 MG / guaifenesin 100 MG / phenylpropanolamine HCl 12.5 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421562 | guaifenesin 800 MG / phenylephrine hydrochloride 25 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421562 | guaifenesin 800 MG / phenylephrine hydrochloride 25 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421613 | amylase 164 UNT/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421614 | protease 139 UNT/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421615 | lipase 25.5 UNT/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421616 | lipase 71,400 UNT / amylase 460,000 UNT / protease 388,000 UNT per 2.8 GM Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421616 | lipase 71,400 UNT / amylase 460,000 UNT / protease 388,000 UNT per 2.8 GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421616 | lipase 71,400 UNT / amylase 460,000 UNT / protease 388,000 UNT per 2.8 GM Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421617 | amylase 164 UNT/MG / lipase 25.5 UNT/MG / protease 139 UNT/MG [PanaKare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421618 | amylase / lipase / protease Oral Powder [PanaKare] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421619 | PanaKare Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421620 | PanaKare Plus 71,400 UNT / 460,000 UNT / 388,000 UNT per 2.8 GM Oral Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421620 | PanaKare Plus 71,400 UNT / 460,000 UNT / 388,000 UNT per 2.8 GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421620 | PanaKare Plus 71,400 UNT / 460,000 UNT / 388,000 UNT per 2.8 GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421620 | PanaKare Plus 71,400 UNT / 460,000 UNT / 388,000 UNT per 2.8 GM Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421621 | methyl glucose dioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1421627 | Ipomoea pes-caprae flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421632 | phenylpropanolamine hydrochloride 1.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421633 | dextromethorphan hydrobromide 5 MG / guaifenesin 100 MG / phenylpropanolamine hydrochloride 6.25 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421633 | dextromethorphan hydrobromide 5 MG / guaifenesin 100 MG / phenylpropanolamine hydrochloride 6.25 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421633 | dextromethorphan hydrobromide 5 MG / guaifenesin 100 MG / phenylpropanolamine hydrochloride 6.25 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421633 | dextromethorphan hydrobromide 5 MG / guaifenesin 100 MG / phenylpropanolamine hydrochloride 6.25 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421634 | dioctyldodecyl dodecanedioate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1421635 | kaolin 190 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421636 | kaolin 19 % / pectin 1 % Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421636 | kaolin 19 % / pectin 1 % Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421637 | urea 25 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421637 | urea 25 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421637 | urea 25 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421638 | phenol 32.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421639 | scarlet red 1.9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421640 | phenol / scarlet red Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421641 | phenol / scarlet red Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1421642 | phenol / scarlet red | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1421643 | phenol 3.25 % / scarlet red 0.19 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421643 | phenol 3.25 % / scarlet red 0.19 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421643 | phenol 3.25 % / scarlet red 0.19 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421644 | bitter almond extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421647 | interferon gamma, porcine recombinant | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1421648 | Interferon gamma | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421648 | Interferon gamma | Designated preferred name (PT) | NO | |
RxCUI: 1421648 | Interferon gamma | Full form of descriptor (FN) | NO | |
RxCUI: 1421648 | Interferon gamma | Designated preferred name (PT) | NO | |
RxCUI: 1421648 | Interferon gamma | Full form of descriptor (FN) | NO | |
RxCUI: 1421649 | guaiFENesin 0.0704 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1421649 | guaiFENesin 0.0704 MG/MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421650 | guaiFENesin Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1421650 | guaiFENesin Oral Powder Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421651 | guaiFENesin Oral Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1421651 | guaiFENesin Oral Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421652 | guaiFENesin 2 GM/OZ Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421652 | guaiFENesin 2 GM/OZ Oral Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421652 | guaiFENesin 2 GM/OZ Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421653 | Spec-tuss | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1421654 | guaiFENesin 0.0704 MG/MG [Spec-tuss] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421654 | guaiFENesin 0.0704 MG/MG [Spec-tuss] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421655 | guaiFENesin Oral Powder [Spec-tuss] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421655 | guaiFENesin Oral Powder [Spec-tuss] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421656 | Spec-tuss Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421657 | Spec-tuss Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421658 | Spec-tuss 2 GM/OZ Oral Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421658 | Spec-tuss 2 GM/OZ Oral Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421658 | Spec-tuss 2 GM/OZ Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421658 | Spec-tuss 2 GM/OZ Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421659 | Oxyrub Pain Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1421660 | menthol 12.5 MG/ML [Oxyrub Pain Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1421661 | menthol Topical Cream [Oxyrub Pain Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421662 | Oxyrub Pain Relief Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421663 | Oxyrub Pain Relief 1.25 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1421663 | Oxyrub Pain Relief 1.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421663 | Oxyrub Pain Relief 1.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421663 | Oxyrub Pain Relief 1.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421877 | {72 (calcium carbonate 1000 MG Chewable Tablet) / 8 (calcium carbonate 750 MG Chewable Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
RxCUI: 1421878 | Tums Ultra Strength 1000 MG 72 Count, Tums Extra 750 MG 8 Count | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
RxCUI: 1421878 | Tums Ultra Strength 1000 MG 72 Count, Tums Extra 750 MG 8 Count | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421878 | Tums Ultra Strength 1000 MG 72 Count, Tums Extra 750 MG 8 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421885 | Chenopodium album whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421886 | Festuca pratensis top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421887 | citric acid 35 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / potassium citrate 85 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421887 | citric acid 35 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / potassium citrate 85 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421887 | citric acid 35 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / potassium citrate 85 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421887 | citric acid 35 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / potassium citrate 85 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421887 | citric acid 35 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / potassium citrate 85 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421887 | citric acid 35 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / potassium citrate 85 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421887 | citric acid 35 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / potassium citrate 85 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421887 | citric acid 35 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / potassium citrate 85 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421888 | dextromethorphan hydrobromide 10 MG/ML / guaifenesin 66.7 MG / pseudoephedrine hydrochloride 20 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421888 | dextromethorphan hydrobromide 10 MG/ML / guaifenesin 66.7 MG / pseudoephedrine hydrochloride 20 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421888 | dextromethorphan hydrobromide 10 MG/ML / guaifenesin 66.7 MG / pseudoephedrine hydrochloride 20 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421888 | dextromethorphan hydrobromide 10 MG/ML / guaifenesin 66.7 MG / pseudoephedrine hydrochloride 20 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421889 | polyglyceryl-10 decaoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421890 | polyglyceryl-6 distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1421891 | dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 20 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421891 | dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 20 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421891 | dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 20 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421891 | dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 20 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421892 | hexyl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1421893 | lidocaine 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1421893 | lidocaine 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1421893 | lidocaine 4 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1421895 | Mata Balm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1421897 | camphor / menthol Topical Ointment [Mata Balm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1421898 | Mata Balm Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1421900 | polyquaternium-39 (31-40-29 acrylic acid-acrylamide-dadmac; 1500000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1421982 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / pseudoephedrine HCl 20 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421982 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / pseudoephedrine HCl 20 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421982 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / pseudoephedrine HCl 20 MG in 5 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421982 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / pseudoephedrine HCl 20 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421982 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / pseudoephedrine HCl 20 MG in 5 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421983 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1421983 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421983 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421983 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421983 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421984 | dextromethorphan hydrobromide 10 MG / guaifenesin 400 MG per 5 ML Syrup | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1421984 | dextromethorphan hydrobromide 10 MG / guaifenesin 400 MG per 5 ML Syrup | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421984 | dextromethorphan hydrobromide 10 MG / guaifenesin 400 MG per 5 ML Syrup | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1421984 | dextromethorphan hydrobromide 10 MG / guaifenesin 400 MG per 5 ML Syrup | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1421985 | chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1421985 | chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1422 | Benzfetamine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422 | Benzfetamine-containing product | Full form of descriptor (FN) | YES | |
RxCUI: 1422 | Benzfetamine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422 | Benzfetamine-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1422 | Benzfetamine-containing product | Designated preferred name (PT) | YES | |
RxCUI: 1422 | Benzfetamine-containing product | Designated preferred name (PT) | YES | |
RxCUI: 1422 | Benzfetamine-containing product | Full form of descriptor (FN) | YES | |
RxCUI: 142206 | Oil of heliotrope | Designated preferred name (PT) | NO | |
RxCUI: 142206 | Oil of heliotrope | Full form of descriptor (FN) | NO | |
RxCUI: 1422060 | Vital-Chlor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1422061 | chlorhexidine gluconate 40 MG/ML [Vital-Chlor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422062 | chlorhexidine Medicated Shampoo [Vital-Chlor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1422063 | Vital-Chlor Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1422064 | Vital-Chlor 4 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422064 | Vital-Chlor 4 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422064 | Vital-Chlor 4 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422064 | Vital-Chlor 4 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422065 | N-alkyl ethylbenzyl dimethyl ammonium chloride (C12-C14) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1422066 | N-alkyl ethylbenzyl dimethyl ammonium (C12-C14) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1422067 | N-alkyl ethylbenzyl dimethyl ammonium chloride (C12-C14) 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1422068 | benzalkonium / chlorhexidine / N-alkyl ethylbenzyl dimethyl ammonium (C12-C14) Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1422069 | benzalkonium / chlorhexidine / N-alkyl ethylbenzyl dimethyl ammonium (C12-C14) Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1422070 | benzalkonium / chlorhexidine / N-alkyl ethylbenzyl dimethyl ammonium (C12-C14) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1422071 | chlorhexidine gluconate 0.5 % / benzalkonium chloride 0.4 % / N-alkyl ethylbenzyl dimethyl NH4Cl (C12-C14) 0.4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422071 | chlorhexidine gluconate 0.5 % / benzalkonium chloride 0.4 % / N-alkyl ethylbenzyl dimethyl NH4Cl (C12-C14) 0.4 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422071 | chlorhexidine gluconate 0.5 % / benzalkonium chloride 0.4 % / N-alkyl ethylbenzyl dimethyl NH4Cl (C12-C14) 0.4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422071 | chlorhexidine gluconate 0.5 % / benzalkonium chloride 0.4 % / N-alkyl ethylbenzyl dimethyl NH4Cl (C12-C14) 0.4 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422072 | Hex-O-Prep | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1422073 | benzalkonium chloride 4 MG/ML / chlorhexidine gluconate 5 MG/ML / N-alkyl ethylbenzyl dimethyl ammonium chloride (C12-C14) 4 MG/ML [Hex-O-Prep] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422074 | benzalkonium / chlorhexidine / N-alkyl ethylbenzyl dimethyl ammonium (C12-C14) Topical Solution [Hex-O-Prep] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1422075 | Hex-O-Prep Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1422076 | Hex-O-Prep 0.5 % / 0.4 % / 0.4 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422076 | Hex-O-Prep 0.5 % / 0.4 % / 0.4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422076 | Hex-O-Prep 0.5 % / 0.4 % / 0.4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422076 | Hex-O-Prep 0.5 % / 0.4 % / 0.4 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422077 | lidocaine 50 MG/ML [AneCream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1422078 | AneCream5 5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422078 | AneCream5 5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422078 | AneCream5 5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422078 | AneCream5 5 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422078 | AneCream5 5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422078 | AneCream5 5 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1422079 | lidocaine 40 MG/ML [AneCream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1422080 | AneCream 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422080 | AneCream 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422080 | AneCream 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422080 | AneCream 4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1422081 | Enskyce 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1422081 | Enskyce 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422081 | Enskyce 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422082 | atorvastatin / ezetimibe Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1422082 | atorvastatin / ezetimibe Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 1422082 | atorvastatin / ezetimibe Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 1422083 | atorvastatin / ezetimibe Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1422084 | atorvastatin / ezetimibe Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1422085 | atorvastatin / ezetimibe | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1422085 | atorvastatin / ezetimibe | Designated preferred name (PT) | YES | |
RxCUI: 1422085 | atorvastatin / ezetimibe | Full form of descriptor (FN) | YES | |
RxCUI: 1422086 | ezetimibe 10 MG / atorvastatin 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422086 | ezetimibe 10 MG / atorvastatin 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1422086 | ezetimibe 10 MG / atorvastatin 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422087 | Liptruzet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1422088 | atorvastatin 10 MG / ezetimibe 10 MG [Liptruzet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422089 | atorvastatin / ezetimibe Oral Tablet [Liptruzet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1422090 | Liptruzet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1422091 | Liptruzet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1422092 | Liptruzet 10 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422092 | Liptruzet 10 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422092 | Liptruzet 10 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422093 | ezetimibe 10 MG / atorvastatin 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422093 | ezetimibe 10 MG / atorvastatin 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1422093 | ezetimibe 10 MG / atorvastatin 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422094 | atorvastatin 20 MG / ezetimibe 10 MG [Liptruzet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422095 | Liptruzet 10 MG / 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422095 | Liptruzet 10 MG / 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422095 | Liptruzet 10 MG / 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422096 | ezetimibe 10 MG / atorvastatin 40 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 1422096 | ezetimibe 10 MG / atorvastatin 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422096 | ezetimibe 10 MG / atorvastatin 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1422096 | ezetimibe 10 MG / atorvastatin 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422096 | ezetimibe 10 MG / atorvastatin 40 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 1422097 | atorvastatin 40 MG / ezetimibe 10 MG [Liptruzet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422098 | Liptruzet 10 MG / 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422098 | Liptruzet 10 MG / 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422098 | Liptruzet 10 MG / 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422099 | ezetimibe 10 MG / atorvastatin 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422099 | ezetimibe 10 MG / atorvastatin 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1422099 | ezetimibe 10 MG / atorvastatin 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422100 | atorvastatin 80 MG / ezetimibe 10 MG [Liptruzet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422101 | Liptruzet 10 MG / 80 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422101 | Liptruzet 10 MG / 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422101 | Liptruzet 10 MG / 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422102 | lidocaine 40 MG/ML [LMX] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1422103 | L-M-X-4 4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1422103 | L-M-X-4 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422103 | L-M-X-4 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422103 | L-M-X-4 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422103 | L-M-X-4 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422104 | lidocaine 50 MG/ML [LMX] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1422105 | lidocaine Rectal Cream [LMX] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1422106 | LMX Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1422107 | L-M-X-5 5 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1422107 | L-M-X-5 5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422107 | L-M-X-5 5 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422107 | L-M-X-5 5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422107 | L-M-X-5 5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422171 | lidocaine 40 MG/ML [Lidocream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1422172 | LidoCream4 4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1422172 | LidoCream4 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422172 | LidoCream4 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422172 | LidoCream4 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422173 | lidocaine 40 MG/ML [Numb Nuts] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422174 | Numb Nuts 4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422174 | Numb Nuts 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422174 | Numb Nuts 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422174 | Numb Nuts 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422175 | Gonabreed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1422176 | gonadorelin 0.1 MG/ML [Gonabreed] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422177 | gonadorelin Injectable Solution [Gonabreed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1422178 | Gonabreed Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1422179 | gonadorelin 0.1 MG/ML Injectable Solution [Gonabreed] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422179 | gonadorelin 0.1 MG/ML Injectable Solution [Gonabreed] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422179 | gonadorelin 0.1 MG/ML Injectable Solution [Gonabreed] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 142218 | Product containing caffeine and sodium benzoate (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 142218 | Product containing caffeine and sodium benzoate (medicinal product) | Designated preferred name (PT) | YES | |
RxCUI: 142218 | Product containing caffeine and sodium benzoate (medicinal product) | Full form of descriptor (FN) | YES | |
RxCUI: 1422180 | Della Barrier | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1422181 | iodine 10 MG/ML [Della Barrier] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422182 | iodine Topical Solution [Della Barrier] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1422183 | Della Barrier Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1422184 | Della Barrier 1 % Iodine Barrier Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422184 | Della Barrier 1 % Iodine Barrier Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422184 | Della Barrier 1 % Iodine Barrier Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422184 | Della Barrier 1 % Iodine Barrier Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422186 | menthol 18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1422187 | Menthol 18 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422187 | Menthol 18 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422188 | menthol 18 MG [Halls] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422189 | Halls 18 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422189 | Halls 18 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422189 | Halls 18 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422193 | poloxamer 403 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1422194 | sodium iodate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 142222 | Lotion | Dose Form (DF) | NO | |
RxCUI: 142243 | Dichlorisone | Designated preferred name (PT) | NO | |
RxCUI: 142243 | Dichlorisone | Full form of descriptor (FN) | NO | |
RxCUI: 142243 | Dichlorisone | Designated preferred name (PT) | NO | |
RxCUI: 142243 | Dichlorisone | Full form of descriptor (FN) | NO | |
RxCUI: 142245 | Hydrocortamate | Designated preferred name (PT) | NO | |
RxCUI: 142245 | Hydrocortamate | Full form of descriptor (FN) | NO | |
RxCUI: 142245 | Hydrocortamate | Designated preferred name (PT) | NO | |
RxCUI: 142245 | Hydrocortamate | Full form of descriptor (FN) | NO | |
RxCUI: 1422476 | lidocaine 40 MG/ML [Ela-Max] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422477 | lidocaine Topical Cream [Ela-Max] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1422478 | Ela-Max Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1422479 | Ela-Max 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422479 | Ela-Max 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422479 | Ela-Max 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422479 | Ela-Max 4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422481 | lidocaine 50 MG/ML [Ela-Max] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422482 | lidocaine Rectal Cream [Ela-Max] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1422483 | Ela-Max Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1422484 | lidocaine 50 MG/ML Rectal Cream [Ela-Max] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422484 | lidocaine 50 MG/ML Rectal Cream [Ela-Max] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422484 | lidocaine 50 MG/ML Rectal Cream [Ela-Max] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422485 | Melaleuca ericifolia leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1422486 | magnesium disodium EDTA | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1422489 | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 30 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422489 | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 30 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 142249 | estradiol Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1422494 | dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / phenylpropanolamine hydrochloride 12.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422494 | dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / phenylpropanolamine hydrochloride 12.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422494 | dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / phenylpropanolamine hydrochloride 12.5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1422494 | dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / phenylpropanolamine hydrochloride 12.5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422494 | dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / phenylpropanolamine hydrochloride 12.5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1422524 | phenylpropanolamine hydrochloride 6.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1422525 | dextromethorphan hydrobromide 5 MG/ML / guaifenesin 50 MG/ML / phenylpropanolamine hydrochloride 6.25 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422525 | dextromethorphan hydrobromide 5 MG/ML / guaifenesin 50 MG/ML / phenylpropanolamine hydrochloride 6.25 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1422545 | lidocaine 50 MG/ML [Recticare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1422546 | RectiCare 5 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1422546 | RectiCare 5 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422546 | RectiCare 5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422546 | RectiCare 5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422556 | Phisoderm Clear Confidence Body Wash | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1422557 | salicylic acid 20 MG/ML [Phisoderm Clear Confidence Body Wash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422558 | salicylic acid Medicated Liquid Soap [Phisoderm Clear Confidence Body Wash] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1422559 | Phisoderm Clear Confidence Body Wash Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1422560 | PHISODERM Anti-Blemish 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422560 | PHISODERM Anti-Blemish 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422560 | PHISODERM Anti-Blemish 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422560 | PHISODERM Anti-Blemish 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422561 | capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422561 | capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422561 | capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1422562 | capsaicin 0.35 MG/ML / lidocaine 20 MG/ML / menthol 50 MG/ML / methyl salicylate 200 MG/ML [Medi-Derm with Lidocaine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1422563 | Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1422563 | Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422563 | Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422564 | Mycocide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1422565 | tolnaftate 10 MG/ML [Mycocide] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422566 | tolnaftate Topical Solution [Mycocide] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1422567 | Mycocide Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1422568 | WOODWARD's MYCOCIDE CLINICAL NS 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422568 | WOODWARD's MYCOCIDE CLINICAL NS 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422568 | WOODWARD's MYCOCIDE CLINICAL NS 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422568 | WOODWARD's MYCOCIDE CLINICAL NS 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422572 | menthol 100 MG/ML [Perform] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422573 | PERFORM 10 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422573 | PERFORM 10 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422573 | PERFORM 10 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422573 | PERFORM 10 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142283 | Digestive enzyme | Designated preferred name (PT) | NO | |
RxCUI: 142283 | Digestive enzyme | Full form of descriptor (FN) | NO | |
RxCUI: 1422884 | chlorpheniramine maleate 0.4 MG/ML / dextromethorphan hydrobromide 2 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422887 | phenylpropanolamine hydrochloride 1.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1422888 | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 1.8 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422888 | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 1.8 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1422891 | dextromethorphan hydrobromide 10 MG / guaifenesin 25 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422891 | dextromethorphan hydrobromide 10 MG / guaifenesin 25 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1422891 | dextromethorphan hydrobromide 10 MG / guaifenesin 25 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422891 | dextromethorphan hydrobromide 10 MG / guaifenesin 25 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1422892 | dextromethorphan hydrobromide 10 MG / guaifenesin 25 MG / pyrilamine maleate 10 MG / sodium citrate 200 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422892 | dextromethorphan hydrobromide 10 MG / guaifenesin 25 MG / pyrilamine maleate 10 MG / sodium citrate 200 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1422892 | dextromethorphan hydrobromide 10 MG / guaifenesin 25 MG / pyrilamine maleate 10 MG / sodium citrate 200 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422892 | dextromethorphan hydrobromide 10 MG / guaifenesin 25 MG / pyrilamine maleate 10 MG / sodium citrate 200 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1422893 | dextromethorphan hydrobromide 2 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422896 | Jencycla 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1422896 | Jencycla 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422896 | Jencycla 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422897 | potassium gluconate 0.00308 MEQ/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1422898 | potassium gluconate Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1422899 | potassium gluconate Oral Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1422900 | potassium gluconate 2 MEQ/0.65 GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422900 | potassium gluconate 2 MEQ/0.65 GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422900 | potassium gluconate 2 MEQ/0.65 GM Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422900 | potassium gluconate 2 MEQ/0.65 GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422900 | potassium gluconate 2 MEQ/0.65 GM Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422901 | dextromethorphan hydrobromide 2 MG/ML / pseudoephedrine hydrochloride 4 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422908 | Della Soft | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1422909 | iodine 5 MG/ML [Della Soft] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422910 | iodine Topical Solution [Della Soft] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1422911 | Della Soft Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1422912 | Della Soft 0.5 % Enhanced Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1422912 | Della Soft 0.5 % Enhanced Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422912 | Della Soft 0.5 % Enhanced Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422912 | Della Soft 0.5 % Enhanced Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422920 | Della Care | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1422921 | iodine 2.5 MG/ML [Della Care] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1422922 | iodine Topical Solution [Della Care] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1422923 | Della Care Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1422924 | iodine 2.5 MG/ML Topical Solution [Della Care] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422924 | iodine 2.5 MG/ML Topical Solution [Della Care] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1422924 | iodine 2.5 MG/ML Topical Solution [Della Care] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1422925 | dextromethorphan hydrobromide 1 MG/ML / pseudoephedrine hydrochloride 2 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1422928 | Aloe arborescens leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1422929 | Prunus domestica subsp. insititia seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1422930 | Scot-tussin Diabetic CF | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1422931 | dextromethorphan hydrobromide 2 MG/ML [Scot-tussin Diabetic CF] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1422932 | dextromethorphan Oral Solution [Scot-tussin Diabetic CF] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1422933 | Scot-tussin Diabetic CF Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1422934 | Scot-tussin Diabetic CF Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1422935 | SCOT-TUSSIN Diabetes Cough Suppressant Formula with DM 10 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1422935 | SCOT-TUSSIN Diabetes Cough Suppressant Formula with DM 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1422935 | SCOT-TUSSIN Diabetes Cough Suppressant Formula with DM 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1422935 | SCOT-TUSSIN Diabetes Cough Suppressant Formula with DM 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423080 | doxycycline hyclate 200 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423080 | doxycycline hyclate 200 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1423082 | DORYX 200 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423082 | DORYX 200 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423082 | DORYX 200 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423082 | DORYX 200 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 142312 | Flavoenzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142312 | Flavoenzyme | Designated preferred name (PT) | NO | |
RxCUI: 142312 | Flavoenzyme | Full form of descriptor (FN) | NO | |
RxCUI: 1423123 | Daysee 91 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1423123 | Daysee 91 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423123 | Daysee 91 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142321 | Hydratase | Designated preferred name (PT) | NO | |
RxCUI: 142321 | Hydratase | Full form of descriptor (FN) | NO | |
RxCUI: 1423224 | Lactobacillus acidophilus 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1423225 | Lactobacillus acidophilus 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423225 | Lactobacillus acidophilus 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423246 | dextromethorphan hydrobromide 30 MG / guaifenesin 1200 MG / phenylephrine hydrochloride 30 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423246 | dextromethorphan hydrobromide 30 MG / guaifenesin 1200 MG / phenylephrine hydrochloride 30 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423270 | technetium (99mTc) sulfur colloid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423270 | technetium (99mTc) sulfur colloid | Designated preferred name (PT) | YES | |
RxCUI: 1423270 | technetium (99mTc) sulfur colloid | Full form of descriptor (FN) | YES | |
RxCUI: 1423270 | technetium (99mTc) sulfur colloid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1423272 | ammonium xylenesulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1423273 | PPG-26-buteth-26 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1423283 | allantoin 0.45 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423286 | allantoin 0.045 % / benzalkonium chloride 0.13 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423286 | allantoin 0.045 % / benzalkonium chloride 0.13 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423286 | allantoin 0.045 % / benzalkonium chloride 0.13 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423287 | Fungisan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423289 | allantoin 0.45 MG/ML / benzalkonium chloride 1.3 MG/ML [Fungisan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423290 | allantoin / benzalkonium Topical Spray [Fungisan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423291 | Fungisan Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423292 | Fungisan 0.13 % / 0.045 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423292 | Fungisan 0.13 % / 0.045 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423292 | Fungisan 0.13 % / 0.045 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423292 | Fungisan 0.13 % / 0.045 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423293 | Earoxide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423294 | carbamide peroxide 65 MG/ML [Earoxide] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423295 | carbamide peroxide Otic Solution [Earoxide] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423296 | Earoxide Otic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423297 | Earoxide 6.5 % Pet Ear Cleanser Otic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423297 | Earoxide 6.5 % Pet Ear Cleanser Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423297 | Earoxide 6.5 % Pet Ear Cleanser Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423297 | Earoxide 6.5 % Pet Ear Cleanser Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423300 | carboxymethylcellulose sodium 0.005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423301 | carboxymethylcellulose sodium 0.5 % Ophthalmic Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423301 | carboxymethylcellulose sodium 0.5 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423303 | dextromethorphan / pyrilamine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1423304 | dextromethorphan / pyrilamine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1423305 | dextromethorphan / pyrilamine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1423306 | dextromethorphan / pyrilamine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1423307 | dextromethorphan HBr 7.5 MG / pyrilamine maleate 7.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423307 | dextromethorphan HBr 7.5 MG / pyrilamine maleate 7.5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1423307 | dextromethorphan HBr 7.5 MG / pyrilamine maleate 7.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423308 | RenaKare | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423309 | potassium gluconate 2 MEQ [RenaKare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423310 | potassium gluconate Oral Tablet [RenaKare] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423311 | RenaKare Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423312 | RenaKare Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423313 | RenaKare 2 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423313 | RenaKare 2 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423313 | RenaKare 2 MEQ Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423313 | RenaKare 2 MEQ Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423313 | RenaKare 2 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423313 | RenaKare 2 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423320 | water 985 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423321 | water 98.5 % Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423321 | water 98.5 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423321 | water 98.5 % Ophthalmic Irrigation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423322 | lidocaine hydrochloride 24 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423323 | benzalkonium chloride 0.1 % / lidocaine HCl 2.4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423323 | benzalkonium chloride 0.1 % / lidocaine HCl 2.4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423323 | benzalkonium chloride 0.1 % / lidocaine HCl 2.4 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423324 | Allercaine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423325 | benzalkonium chloride 1 MG/ML / lidocaine hydrochloride 24 MG/ML [Allercaine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423326 | benzalkonium / lidocaine Topical Spray [Allercaine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423327 | Allercaine Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423328 | Allercaine with Bittran II 2.4 % / 0.1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423328 | Allercaine with Bittran II 2.4 % / 0.1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423328 | Allercaine with Bittran II 2.4 % / 0.1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423328 | Allercaine with Bittran II 2.4 % / 0.1 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423345 | tribulus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423388 | ReliOn Glucose | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423389 | cholecalciferol 6.67 UNT/ML / glucose 250 MG/ML [ReliOn Glucose] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423390 | cholecalciferol / glucose Oral Solution [ReliOn Glucose] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423391 | ReliOn Glucose Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423392 | ReliOn Glucose Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423393 | cholecalciferol 6.67 UNT/ML / glucose 250 MG/ML Oral Solution [ReliOn Glucose] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423393 | cholecalciferol 6.67 UNT/ML / glucose 250 MG/ML Oral Solution [ReliOn Glucose] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423396 | zeaxanthin 0.24 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423397 | lutein 6 MG / zeaxanthin 240 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423397 | lutein 6 MG / zeaxanthin 240 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423401 | dextromethorphan hydrobromide 20 MG / guaifenesin 800 MG / phenylephrine hydrochloride 20 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423401 | dextromethorphan hydrobromide 20 MG / guaifenesin 800 MG / phenylephrine hydrochloride 20 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423408 | camphor / phenol / tannic acid / zinc oxide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1423409 | camphor / phenol / tannic acid / zinc oxide Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1423410 | zinc oxide 6.6 % / camphor 3 % / phenol 2.5 % / tannic acid 2.2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1423410 | zinc oxide 6.6 % / camphor 3 % / phenol 2.5 % / tannic acid 2.2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423410 | zinc oxide 6.6 % / camphor 3 % / phenol 2.5 % / tannic acid 2.2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423410 | zinc oxide 6.6 % / camphor 3 % / phenol 2.5 % / tannic acid 2.2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423411 | Unguentine Maximum Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423412 | camphor 0.03 MG/MG / phenol 0.025 MG/MG / tannic acid 0.022 MG/MG / zinc oxide 0.066 MG/MG [Unguentine Maximum Strength] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423413 | camphor / phenol / tannic acid / zinc oxide Topical Ointment [Unguentine Maximum Strength] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423414 | Unguentine Maximum Strength Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423415 | camphor 0.03 MG/MG / phenol 0.025 MG/MG / tannic acid 0.022 MG/MG / zinc oxide 0.066 MG/MG Topical Ointment [Unguentine Maximum Strength] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423415 | camphor 0.03 MG/MG / phenol 0.025 MG/MG / tannic acid 0.022 MG/MG / zinc oxide 0.066 MG/MG Topical Ointment [Unguentine Maximum Strength] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423415 | camphor 0.03 MG/MG / phenol 0.025 MG/MG / tannic acid 0.022 MG/MG / zinc oxide 0.066 MG/MG Topical Ointment [Unguentine Maximum Strength] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423416 | guaiFENesin 1000 MG / phenylephrine HCl 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423416 | guaiFENesin 1000 MG / phenylephrine HCl 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423416 | guaiFENesin 1000 MG / phenylephrine HCl 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423416 | guaiFENesin 1000 MG / phenylephrine HCl 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423416 | guaiFENesin 1000 MG / phenylephrine HCl 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423423 | vitamin B12 (cyanocobalamin) 1000 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423423 | vitamin B12 (cyanocobalamin) 1000 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423423 | vitamin B12 (cyanocobalamin) 1000 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1423424 | guaifenesin 800 MG / phenylephrine hydrochloride 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423424 | guaifenesin 800 MG / phenylephrine hydrochloride 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423457 | aluminum hydroxyphosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423458 | 24-homo-1,25-dihydroxyvitamin D3 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1423459 | Triumph | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423460 | iodine 10 MG/ML [Triumph] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423461 | iodine Topical Solution [Triumph] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423462 | Triumph Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423463 | Triumph 1 % for adverse weather Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423463 | Triumph 1 % for adverse weather Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423463 | Triumph 1 % for adverse weather Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423463 | Triumph 1 % for adverse weather Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423464 | Agro Dip Concentrate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423465 | iodine 20 MG/ML [Agro Dip Concentrate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423466 | iodine Topical Solution [Agro Dip Concentrate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423467 | Agro Dip Concentrate Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423468 | iodine 20 MG/ML Topical Solution [Agro Dip Concentrate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423468 | iodine 20 MG/ML Topical Solution [Agro Dip Concentrate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423468 | iodine 20 MG/ML Topical Solution [Agro Dip Concentrate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423469 | heptanoic acid 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423470 | lactic acid 14 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423471 | heptanoic acid / lactate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1423472 | heptanoic acid / lactate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1423473 | heptanoic acid / lactate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1423474 | lactic acid 1.4 % / heptanoic acid 0.3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423474 | lactic acid 1.4 % / heptanoic acid 0.3 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423474 | lactic acid 1.4 % / heptanoic acid 0.3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423475 | Valiant Shield | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423476 | heptanoic acid 3 MG/ML / lactic acid 14 MG/ML [Valiant Shield] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423477 | heptanoic acid / lactate Topical Solution [Valiant Shield] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423478 | Valiant Shield Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423479 | Valiant Shield 1.4 % / 0.3 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423479 | Valiant Shield 1.4 % / 0.3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423479 | Valiant Shield 1.4 % / 0.3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423480 | levothyroxine sodium 0.0022 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423482 | levothyroxine Oral Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1423483 | levothyroxine sodium 1 GM per 453.6 GM Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423483 | levothyroxine sodium 1 GM per 453.6 GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423483 | levothyroxine sodium 1 GM per 453.6 GM Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423484 | PancrePlus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423485 | amylase 64000 UNT / lipase 9000 UNT / protease 57000 UNT [PancrePlus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423486 | amylase / lipase / protease Oral Tablet [PancrePlus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423487 | PancrePlus Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423488 | PancrePlus Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423489 | PancrePlus 9000 UNT / 64,000 UNT / 57,000 UNT Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423489 | PancrePlus 9000 UNT / 64,000 UNT / 57,000 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423489 | PancrePlus 9000 UNT / 64,000 UNT / 57,000 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423489 | PancrePlus 9000 UNT / 64,000 UNT / 57,000 UNT Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423490 | Phisoderm Clear Confidence Daily Gel Face Wash | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423491 | salicylic acid 20 MG/ML [Phisoderm Clear Confidence Daily Gel Face Wash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423492 | salicylic acid Medicated Liquid Soap [Phisoderm Clear Confidence Daily Gel Face Wash] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423493 | Phisoderm Clear Confidence Daily Gel Face Wash Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423494 | PHISODERM 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423494 | PHISODERM 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423494 | PHISODERM 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423494 | PHISODERM 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 14236 | L-3-aminobutyryl-CoA deaminase | Designated preferred name (PT) | NO | |
RxCUI: 14236 | L-3-aminobutyryl-CoA deaminase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 14236 | L-3-aminobutyryl-CoA deaminase | Full form of descriptor (FN) | NO | |
RxCUI: 14236 | L-3-aminobutyryl-CoA deaminase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423659 | acyclovir 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1423660 | acyclovir Buccal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1423661 | acyclovir Buccal Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1423662 | acyclovir 50 MG Buccal Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423662 | acyclovir 50 MG Buccal Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1423662 | acyclovir 50 MG Buccal Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423667 | lead acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423668 | Tri-Heart Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423669 | ivermectin 0.136 MG / pyrantel 114 MG [Tri-Heart Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423670 | ivermectin / pyrantel Chewable Tablet [Tri-Heart Plus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423671 | Tri-Heart Plus Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423672 | Tri-Heart Plus Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423673 | Tri-Heart Plus Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423674 | Tri-Heart Plus for Dogs 136 MCG / 114 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423674 | Tri-Heart Plus for Dogs 136 MCG / 114 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423674 | Tri-Heart Plus for Dogs 136 MCG / 114 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423675 | ivermectin 0.272 MG / pyrantel 227 MG [Tri-Heart Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423676 | Tri-Heart Plus for Dogs 272 MCG / 227 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423676 | Tri-Heart Plus for Dogs 272 MCG / 227 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423676 | Tri-Heart Plus for Dogs 272 MCG / 227 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423677 | ivermectin 0.068 MG / pyrantel 57 MG [Tri-Heart Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423678 | Tri-Heart Plus for Dogs 68 MCG / 57 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423678 | Tri-Heart Plus for Dogs 68 MCG / 57 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423678 | Tri-Heart Plus for Dogs 68 MCG / 57 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423680 | petrolatum 0.324 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423681 | petrolatum 32.4 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423681 | petrolatum 32.4 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423681 | petrolatum 32.4 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423683 | glyceryl palmitostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1423684 | hypophosphorous acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1423685 | sodium fluoride 0.51 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423686 | sodium fluoride 0.051 % (fluoride ion 0.22 % ) Oral Rinse | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423686 | sodium fluoride 0.051 % (fluoride ion 0.22 % ) Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423686 | sodium fluoride 0.051 % (fluoride ion 0.22 % ) Oral Rinse | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423691 | melatonin 1 MG Sublingual Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423691 | melatonin 1 MG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1423702 | brompheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1423702 | brompheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423702 | brompheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423709 | chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 75 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423709 | chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 75 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423709 | chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 75 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423709 | chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 75 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423710 | chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylpropanolamine hydrochloride 12.5 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423710 | chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylpropanolamine hydrochloride 12.5 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423711 | chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1423711 | chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423711 | chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423718 | dextromethorphan hydrobromide 10 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423718 | dextromethorphan hydrobromide 10 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423719 | pyrilamine maleate 1.77 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423720 | dextromethorphan hydrobromide 2 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.77 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423766 | niMODipine 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1423766 | niMODipine 3 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1423767 | niMODipine 60 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423767 | niMODipine 60 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1423767 | niMODipine 60 MG in 20 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1423767 | niMODipine 60 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1423767 | niMODipine 60 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423767 | niMODipine 60 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1423767 | niMODipine 60 MG in 20 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423767 | niMODipine 60 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423767 | niMODipine 60 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1423768 | Nymalize | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1423769 | niMODipine 3 MG/ML [Nymalize] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1423769 | niMODipine 3 MG/ML [Nymalize] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1423770 | niMODipine Oral Solution [Nymalize] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1423770 | niMODipine Oral Solution [Nymalize] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1423771 | Nymalize Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1423772 | Nymalize Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1423773 | Nymalize 60 MG in 20 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1423773 | Nymalize 60 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1423773 | Nymalize 60 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423773 | Nymalize 60 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423773 | Nymalize 60 MG in 20 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423773 | Nymalize 60 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423779 | dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423779 | dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423779 | dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423779 | dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423780 | C30-50 alcohols | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423781 | 4-allyl-2,6-dimethoxyphenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423782 | isomethyleugenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423783 | dextromethorphan hydrobromide 10 MG / guaifenesin 85 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423783 | dextromethorphan hydrobromide 10 MG / guaifenesin 85 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423783 | dextromethorphan hydrobromide 10 MG / guaifenesin 85 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423783 | dextromethorphan hydrobromide 10 MG / guaifenesin 85 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423791 | sucrose tetrastearate triacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423792 | tiliroside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423793 | sodium lauryl glycol carboxylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1423794 | dextromethorphan hydrobromide 10 MG / guaifenesin 67 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423794 | dextromethorphan hydrobromide 10 MG / guaifenesin 67 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423794 | dextromethorphan hydrobromide 10 MG / guaifenesin 67 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423794 | dextromethorphan hydrobromide 10 MG / guaifenesin 67 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423795 | dextromethorphan hydrobromide 10 MG / guaifenesin 50 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423795 | dextromethorphan hydrobromide 10 MG / guaifenesin 50 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423795 | dextromethorphan hydrobromide 10 MG / guaifenesin 50 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423795 | dextromethorphan hydrobromide 10 MG / guaifenesin 50 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423796 | cuprous chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1423797 | hollyleaved barberry whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423797 | hollyleaved barberry whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423797 | hollyleaved barberry whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423798 | chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423798 | chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423798 | chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423798 | chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1423799 | sodium molybdate dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1423801 | chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 12.5 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423801 | chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 12.5 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423802 | sodium glycerophosphate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1423803 | glyceryl phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1423805 | glyceryl phosphate Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1423807 | sodium glycerophosphate 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1423807 | sodium glycerophosphate 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423807 | sodium glycerophosphate 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423808 | Glycophos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1423811 | Glycophos Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1423812 | Glycophos 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423812 | Glycophos 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1423812 | Glycophos 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423812 | Glycophos 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423813 | potassium iodide 65 MG [Iosat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1423814 | Iosat 65 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423814 | Iosat 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423814 | Iosat 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423814 | Iosat 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423814 | Iosat 65 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1423815 | LEROSETT | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423820 | menthol 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423820 | menthol 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423820 | menthol 1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423826 | menthol 3 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423826 | menthol 3 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423826 | menthol 3 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423827 | Marathon Pain Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423828 | menthol 30 MG/ML [Marathon Pain Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423829 | menthol Topical Lotion [Marathon Pain Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423830 | Marathon Pain Relief Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423831 | Marathon Pain Relief 3 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423831 | Marathon Pain Relief 3 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423831 | Marathon Pain Relief 3 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423831 | Marathon Pain Relief 3 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423833 | chlorpheniramine maleate 0.266 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1423834 | chlorpheniramine maleate 1.33 MG / dextromethorphan hydrobromide 10 MG / pseudoephedrine hydrochloride 20 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423834 | chlorpheniramine maleate 1.33 MG / dextromethorphan hydrobromide 10 MG / pseudoephedrine hydrochloride 20 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423835 | salicylic acid 20 MG/ML [LEROSETT] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423836 | salicylic acid Medicated Liquid Soap [LEROSETT] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423837 | LEROSETT Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423838 | LEROSETT 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423838 | LEROSETT 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423838 | LEROSETT 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423838 | LEROSETT 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423845 | APAP 43.3 MG/ML / dextromethorphan hydrobromide 2 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423845 | APAP 43.3 MG/ML / dextromethorphan hydrobromide 2 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423913 | antimony triiodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423914 | silver iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423921 | California poppy flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423921 | California poppy flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423922 | cobaltous nitrate hexahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1423923 | cobaltous nitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423924 | corn meal extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1423924 | corn meal extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423925 | ubiquinone Q2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1423931 | West Dip | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423932 | iodine 10 MG/ML [West Dip] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423933 | iodine Topical Solution [West Dip] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423934 | West Dip Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423935 | West Dip 1 % Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423935 | West Dip 1 % Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423935 | West Dip 1 % Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423935 | West Dip 1 % Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423936 | Blockade | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423937 | iodine 10 MG/ML [Blockade] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423938 | iodine Topical Solution [Blockade] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423939 | Blockade Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423940 | BLOCKADE 1 % Barrier Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423940 | BLOCKADE 1 % Barrier Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423940 | BLOCKADE 1 % Barrier Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423940 | BLOCKADE 1 % Barrier Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423941 | Bovadine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423942 | iodine 10 MG/ML [Bovadine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423943 | iodine Topical Solution [Bovadine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423944 | Bovadine Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423945 | Bovadine 1 % Sanitizing Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423945 | Bovadine 1 % Sanitizing Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423945 | Bovadine 1 % Sanitizing Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423945 | Bovadine 1 % Sanitizing Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423946 | iodine 4.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423947 | iodine 0.42 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423947 | iodine 0.42 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423947 | iodine 0.42 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423948 | QuarterMate Concentrate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423949 | iodine 4.2 MG/ML [QuarterMate Concentrate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423950 | iodine Topical Solution [QuarterMate Concentrate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423951 | QuarterMate Concentrate Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423952 | QuarterMate Concentrate With Glycerin 0.42 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423952 | QuarterMate Concentrate With Glycerin 0.42 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423952 | QuarterMate Concentrate With Glycerin 0.42 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423952 | QuarterMate Concentrate With Glycerin 0.42 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423957 | Prepodyne | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1423958 | iodine 10 MG/ML [Prepodyne] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1423959 | iodine Topical Solution [Prepodyne] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1423960 | Prepodyne Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1423961 | Prepodyne Pre/post-surgical Skin Antiseptic 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423961 | Prepodyne Pre/post-surgical Skin Antiseptic 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423961 | Prepodyne Pre/post-surgical Skin Antiseptic 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423961 | Prepodyne Pre/post-surgical Skin Antiseptic 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423962 | Wal-Hist 12 HR Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1423963 | clemastine fumarate 1.34 MG [Wal-Hist 12 HR Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1423964 | clemastine Extended Release Oral Tablet [Wal-Hist 12 HR Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1423965 | Wal-Hist 12 HR Relief Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1423966 | Wal-Hist 12 HR Relief Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1423967 | Wal-Hist 12 HR Relief 1.34 MG 12HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1423967 | Wal-Hist 12 HR Relief 1.34 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423967 | Wal-Hist 12 HR Relief 1.34 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1423967 | Wal-Hist 12 HR Relief 1.34 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423968 | clemastine fumarate 1.34 MG Extended Release Oral Tablet [Wal-Hist 12 HR Relief] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1423968 | clemastine fumarate 1.34 MG Extended Release Oral Tablet [Wal-Hist 12 HR Relief] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423970 | amylase 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423971 | protease 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423972 | papain 16 MG / amylase 2 MG / protease 2 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423972 | papain 16 MG / amylase 2 MG / protease 2 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423972 | papain 16 MG / amylase 2 MG / protease 2 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423974 | lanolin 0.37 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1423975 | lanolin 37 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1423975 | lanolin 37 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1423975 | lanolin 37 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1423977 | camphor 0.5 % / menthol 0.3 % / methyl salicylate 1 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1423977 | camphor 0.5 % / menthol 0.3 % / methyl salicylate 1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1423977 | camphor 0.5 % / menthol 0.3 % / methyl salicylate 1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424 | Benzatropine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424 | Benzatropine-containing product | Full form of descriptor (FN) | YES | |
RxCUI: 1424 | Benzatropine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424 | Benzatropine-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424 | Benzatropine-containing product | Designated preferred name (PT) | YES | |
RxCUI: 1424 | Benzatropine-containing product | Designated preferred name (PT) | YES | |
RxCUI: 1424 | Benzatropine-containing product | Full form of descriptor (FN) | YES | |
RxCUI: 1424005 | benzoyl peroxide / salicylic acid / sulfur Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1424006 | benzoyl peroxide / salicylic acid / sulfur Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1424007 | benzoyl peroxide / salicylic acid / sulfur | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1424008 | benzoyl peroxide 3 % / salicylic acid 2 % / sulfur 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424008 | benzoyl peroxide 3 % / salicylic acid 2 % / sulfur 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424008 | benzoyl peroxide 3 % / salicylic acid 2 % / sulfur 2 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424009 | Vital-Benz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1424010 | benzoyl peroxide 30 MG/ML / salicylic acid 20 MG/ML / sulfur 20 MG/ML [Vital-Benz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1424011 | benzoyl peroxide / salicylic acid / sulfur Medicated Shampoo [Vital-Benz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1424012 | Vital-Benz Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1424013 | Vital-Benz 3 % / 2 % / 2 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424013 | Vital-Benz 3 % / 2 % / 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424013 | Vital-Benz 3 % / 2 % / 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424014 | chlorhexidine / ketoconazole Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1424015 | chlorhexidine / ketoconazole Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1424016 | chlorhexidine gluconate 2 % / ketoconazole 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424016 | chlorhexidine gluconate 2 % / ketoconazole 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424016 | chlorhexidine gluconate 2 % / ketoconazole 1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424017 | Vital-Ketodine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1424018 | chlorhexidine gluconate 20 MG/ML / ketoconazole 10 MG/ML [Vital-Ketodine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1424019 | chlorhexidine / ketoconazole Medicated Shampoo [Vital-Ketodine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 142402 | Aluminum paste | British preferred term (PTGB) | NO | |
RxCUI: 142402 | Aluminum paste | Full form of descriptor (FN) | NO | |
RxCUI: 142402 | Aluminum paste | Designated preferred name (PT) | NO | |
RxCUI: 1424020 | Vital-Ketodine Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1424021 | Vital-KetoDine 2 % / 1 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424021 | Vital-KetoDine 2 % / 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424021 | Vital-KetoDine 2 % / 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424023 | dextromethorphan hydrobromide 10 MG / methoxyphenamine 17 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424023 | dextromethorphan hydrobromide 10 MG / methoxyphenamine 17 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424024 | dextromethorphan hydrobromide 10 MG / guaiacolsulfonate 75 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424024 | dextromethorphan hydrobromide 10 MG / guaiacolsulfonate 75 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424029 | dextromethorphan hydrobromide 20 MG / guaifenesin 1200 MG / phenylephrine hydrochloride 40 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424029 | dextromethorphan hydrobromide 20 MG / guaifenesin 1200 MG / phenylephrine hydrochloride 40 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424032 | dextromethorphan hydrobromide 30 MG / guaifenesin 1200 MG / phenylephrine hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424032 | dextromethorphan hydrobromide 30 MG / guaifenesin 1200 MG / phenylephrine hydrochloride 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424037 | benzalkonium chloride 0.13 % / lidocaine 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424037 | benzalkonium chloride 0.13 % / lidocaine 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424037 | benzalkonium chloride 0.13 % / lidocaine 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424042 | chloroxylenol 2 % / lidocaine 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424042 | chloroxylenol 2 % / lidocaine 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424043 | chloroxylenol 20 MG/ML / lidocaine 20 MG/ML [Unguentine Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1424044 | chloroxylenol 20 MG/ML / lidocaine 20 MG/ML Topical Cream [Unguentine Plus] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424044 | chloroxylenol 20 MG/ML / lidocaine 20 MG/ML Topical Cream [Unguentine Plus] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424045 | chlorpheniramine maleate 1 MG / dextromethorphan hydrobromide 5 MG / phenylpropanolamine hydrochloride 6.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424048 | hydrocortisone / lidocaine Rectal Cream [Rectacreme] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1424049 | Rectacreme Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1424050 | hydrocortisone acetate 5 MG/ML / lidocaine hydrochloride 30 MG/ML Rectal Cream [Rectacreme] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424050 | hydrocortisone acetate 5 MG/ML / lidocaine hydrochloride 30 MG/ML Rectal Cream [Rectacreme] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424051 | dextromethorphan hydrobromide 2 MG/ML / terpin hydrate 17 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424052 | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 3 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424052 | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 3 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424060 | chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 2 MG/ML / guaifenesin 5 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424060 | chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 2 MG/ML / guaifenesin 5 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424061 | dextromethorphan hydrobromide 10 MG / guaiacolsulfonate 200 MG / guaifenesin 25 MG / pyrilamine maleate 10 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424061 | dextromethorphan hydrobromide 10 MG / guaiacolsulfonate 200 MG / guaifenesin 25 MG / pyrilamine maleate 10 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424061 | dextromethorphan hydrobromide 10 MG / guaiacolsulfonate 200 MG / guaifenesin 25 MG / pyrilamine maleate 10 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424061 | dextromethorphan hydrobromide 10 MG / guaiacolsulfonate 200 MG / guaifenesin 25 MG / pyrilamine maleate 10 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424062 | dextromethorphan hydrobromide 10 MG / guaiacolsulfonate 200 MG / guaifenesin 25 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424062 | dextromethorphan hydrobromide 10 MG / guaiacolsulfonate 200 MG / guaifenesin 25 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424062 | dextromethorphan hydrobromide 10 MG / guaiacolsulfonate 200 MG / guaifenesin 25 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424062 | dextromethorphan hydrobromide 10 MG / guaiacolsulfonate 200 MG / guaifenesin 25 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424065 | Dextromethorphan Hydrobromide 2 MG/ML / Phenylephrine Hydrochloride 1 MG/ML / Pot guaiacolsulfonate 15 MG/ML / Pyrilamine Maleate 1.77 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424065 | Dextromethorphan Hydrobromide 2 MG/ML / Phenylephrine Hydrochloride 1 MG/ML / Pot guaiacolsulfonate 15 MG/ML / Pyrilamine Maleate 1.77 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424065 | Dextromethorphan Hydrobromide 2 MG/ML / Phenylephrine Hydrochloride 1 MG/ML / Pot guaiacolsulfonate 15 MG/ML / Pyrilamine Maleate 1.77 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424065 | Dextromethorphan Hydrobromide 2 MG/ML / Phenylephrine Hydrochloride 1 MG/ML / Pot guaiacolsulfonate 15 MG/ML / Pyrilamine Maleate 1.77 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424066 | dextromethorphan hydrobromide 10 MG / guaiacolsulfonate 75 MG / phenylephrine hydrochloride 5 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424066 | dextromethorphan hydrobromide 10 MG / guaiacolsulfonate 75 MG / phenylephrine hydrochloride 5 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142407 | Calcium ascorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 142407 | Calcium ascorbate | Designated preferred name (PT) | YES | |
RxCUI: 142407 | Calcium ascorbate | Full form of descriptor (FN) | YES | |
RxCUI: 14241 | Beta aminoisobutyric acid | Designated preferred name (PT) | NO | |
RxCUI: 14241 | Beta aminoisobutyric acid | Full form of descriptor (FN) | NO | |
RxCUI: 1424173 | dimethicone PEG-7 phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424174 | radium chloride Ra-223 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1424176 | dextromethorphan hydrobromide 2 MG/ML / guaiacolsulfonate 15 MG/ML [Guacol DM] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1424177 | dextromethorphan hydrobromide 2 MG/ML / guaiacolsulfonate 15 MG/ML Oral Solution [Guacol DM] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424177 | dextromethorphan hydrobromide 2 MG/ML / guaiacolsulfonate 15 MG/ML Oral Solution [Guacol DM] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424178 | dextromethorphan hydrobromide 2 MG/ML / guaiacolsulfonate 15 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.77 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424214 | radium Ra-223 1100 kBq/ML in 6 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424214 | radium Ra-223 1100 kBq/ML in 6 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424214 | radium Ra-223 1100 kBq/ML in 6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424214 | radium Ra-223 1100 kBq/ML in 6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424215 | Xofigo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1424218 | Xofigo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1424219 | Xofigo 1100 kBq/ML in 6 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1424219 | Xofigo 1100 kBq/ML in 6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424219 | Xofigo 1100 kBq/ML in 6 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424219 | Xofigo 1100 kBq/ML in 6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424229 | Benzoyl-Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1424230 | benzoyl peroxide 25 MG/ML [Benzoyl-Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1424231 | benzoyl peroxide Medicated Shampoo [Benzoyl-Plus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1424232 | Benzoyl-Plus Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1424233 | Benzoyl Plus 2.5 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424233 | Benzoyl Plus 2.5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424233 | Benzoyl Plus 2.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424233 | Benzoyl Plus 2.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424236 | eucalyptol 0.0091 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424237 | menthol 0.0001 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424238 | methyl salicylate 0.0055 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424239 | thymol 0.0063 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 142424 | Amiloride hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142424 | Amiloride hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142424 | Amiloride hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 142424 | Amiloride hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 1424240 | eucalyptol / menthol / methyl salicylate / thymol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1424241 | eucalyptol / menthol / methyl salicylate / thymol Topical Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1424242 | eucalyptol 0.091 % / menthol 0.01 % / methyl salicylate 0.055 % / thymol 0.063 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424242 | eucalyptol 0.091 % / menthol 0.01 % / methyl salicylate 0.055 % / thymol 0.063 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424242 | eucalyptol 0.091 % / menthol 0.01 % / methyl salicylate 0.055 % / thymol 0.063 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424243 | iodine 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424244 | iodine 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424244 | iodine 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424244 | iodine 0.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424245 | Quarter Mate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1424246 | iodine 1 MG/ML [Quarter Mate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1424247 | iodine Topical Solution [Quarter Mate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1424248 | Quarter Mate Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1424249 | Quarter Mate/Plus w/ Io-Maxx 0.1 % Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424249 | Quarter Mate/Plus w/ Io-Maxx 0.1 % Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424249 | Quarter Mate/Plus w/ Io-Maxx 0.1 % Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424249 | Quarter Mate/Plus w/ Io-Maxx 0.1 % Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 142425 | Benzfetamine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142425 | Benzfetamine hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 142425 | Benzfetamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142425 | Benzfetamine hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 1424250 | Dermal-Soothe | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1424251 | pramoxine hydrochloride 10 MG/ML [Dermal-Soothe] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1424252 | pramoxine Medicated Shampoo [Dermal-Soothe] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1424253 | Dermal-Soothe Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1424254 | Dermal-Soothe 1 % Medicated Conditioner | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424254 | Dermal-Soothe 1 % Medicated Conditioner | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424254 | Dermal-Soothe 1 % Medicated Conditioner | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424254 | Dermal-Soothe 1 % Medicated Conditioner | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424255 | pramoxine Topical Spray [Dermal-Soothe] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1424256 | Dermal-Soothe Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1424257 | Dermal-Soothe 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424257 | Dermal-Soothe 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424257 | Dermal-Soothe 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424257 | Dermal-Soothe 1 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 142426 | Bromocriptine mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142426 | Bromocriptine mesilate | Full form of descriptor (FN) | YES | |
RxCUI: 142426 | Bromocriptine mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142426 | Bromocriptine mesilate | Designated preferred name (PT) | YES | |
RxCUI: 1424266 | Lobelia cardinalis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424266 | Lobelia cardinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424266 | Lobelia cardinalis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424267 | Semecarpus anacardium fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424268 | sodium stearoamphoacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1424269 | stearoamphoacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 142427 | Parabromdylamine maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142427 | Parabromdylamine maleate | Designated preferred name (PT) | YES | |
RxCUI: 142427 | Parabromdylamine maleate | Full form of descriptor (FN) | YES | |
RxCUI: 142427 | Parabromdylamine maleate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424270 | N-lactoylethanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424273 | iron carbonyl (as iron) 65 MG / ascorbic acid 125 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424273 | iron carbonyl (as iron) 65 MG / ascorbic acid 125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424273 | iron carbonyl (as iron) 65 MG / ascorbic acid 125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424273 | iron carbonyl (as iron) 65 MG / ascorbic acid 125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424274 | dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424274 | dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424274 | dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142428 | Chlorguanide hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142428 | Chlorguanide hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142428 | Chlorguanide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142428 | Chlorguanide hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142428 | Chlorguanide hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 1424281 | vitamin E 30,000 UNT Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424281 | vitamin E 30,000 UNT Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424281 | vitamin E 30,000 UNT Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424283 | New-Skin Liquid Bandage | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1424284 | benzethonium chloride 2 MG/ML [New-Skin Liquid Bandage] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1424285 | benzethonium Topical Spray [New-Skin Liquid Bandage] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1424286 | New-Skin Liquid Bandage Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1424287 | New-Skin Liquid Bandage 0.2 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1424287 | New-Skin Liquid Bandage 0.2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424287 | New-Skin Liquid Bandage 0.2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424287 | New-Skin Liquid Bandage 0.2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424288 | dimethicone 1 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424289 | dimethicone 100 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424289 | dimethicone 100 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424289 | dimethicone 100 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142429 | Chlorphenamine maleate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142429 | Chlorphenamine maleate | Full form of descriptor (FN) | YES | |
RxCUI: 142429 | Chlorphenamine maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142429 | Chlorphenamine maleate | Designated preferred name (PT) | YES | |
RxCUI: 1424290 | New-Skin Scar Fade | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1424291 | dimethicone 1 MG/MG [New-Skin Scar Fade] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1424292 | dimethicone Topical Gel [New-Skin Scar Fade] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1424293 | New-Skin Scar Fade Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1424294 | new-skin SCAR FADE 100 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424294 | new-skin SCAR FADE 100 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424294 | new-skin SCAR FADE 100 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424294 | new-skin SCAR FADE 100 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424295 | codeine phosphate 8 MG / acetaminophen 325 MG / chlorpheniramine maleate 2 MG / pseudoephedrine HCl 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424295 | codeine phosphate 8 MG / acetaminophen 325 MG / chlorpheniramine maleate 2 MG / pseudoephedrine HCl 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424295 | codeine phosphate 8 MG / acetaminophen 325 MG / chlorpheniramine maleate 2 MG / pseudoephedrine HCl 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424296 | codeine phosphate 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424297 | codeine phosphate 6 MG / acetaminophen 500 MG / pseudoephedrine HCl 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424297 | codeine phosphate 6 MG / acetaminophen 500 MG / pseudoephedrine HCl 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424297 | codeine phosphate 6 MG / acetaminophen 500 MG / pseudoephedrine HCl 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424298 | APAP 500 MG / Codeine Phosphate 8 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424298 | APAP 500 MG / Codeine Phosphate 8 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424299 | APAP 500 MG / codeine phosphate 9 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424299 | APAP 500 MG / codeine phosphate 9 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142430 | Meclastine fumarate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142430 | Meclastine fumarate | Designated preferred name (PT) | YES | |
RxCUI: 142430 | Meclastine fumarate | Full form of descriptor (FN) | YES | |
RxCUI: 142430 | Meclastine fumarate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142430 | Meclastine fumarate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424300 | codeine phosphate 20 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424301 | clemastine fumarate 0.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424302 | APAP 325 MG / clemastine fumarate 0.25 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424302 | APAP 325 MG / clemastine fumarate 0.25 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424303 | APAP 325 MG / clemastine fumarate 0.33 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424303 | APAP 325 MG / clemastine fumarate 0.33 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424304 | pseudoephedrine hydrochloride 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424306 | chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424307 | carbinoxamine maleate 4 MG / pseudoephedrine HCl 60 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424307 | carbinoxamine maleate 4 MG / pseudoephedrine HCl 60 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424307 | carbinoxamine maleate 4 MG / pseudoephedrine HCl 60 MG Chewable Tablet | Designated preferred name (PT) | NO | |
RxCUI: 1424307 | carbinoxamine maleate 4 MG / pseudoephedrine HCl 60 MG Chewable Tablet | Full form of descriptor (FN) | NO | |
RxCUI: 1424308 | dexbrompheniramine maleate 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424309 | dexbrompheniramine maleate 4 MG / pseudoephedrine HCl 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424309 | dexbrompheniramine maleate 4 MG / pseudoephedrine HCl 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142431 | Clomifene citrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142431 | Clomifene citrate | Full form of descriptor (FN) | YES | |
RxCUI: 142431 | Clomifene citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142431 | Clomifene citrate | Designated preferred name (PT) | YES | |
RxCUI: 142431 | Clomifene citrate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1424313 | 12 HR APAP 500 MG / Loratadine 2.5 MG / Pseudoephedrine sulfate 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424313 | 12 HR APAP 500 MG / Loratadine 2.5 MG / Pseudoephedrine sulfate 60 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424313 | 12 HR APAP 500 MG / Loratadine 2.5 MG / Pseudoephedrine sulfate 60 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424314 | APAP 500 MG / Loratadine 2.5 MG / Pseudoephedrine sulfate 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424314 | APAP 500 MG / Loratadine 2.5 MG / Pseudoephedrine sulfate 60 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 142432 | Clonidine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142432 | Clonidine hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142432 | Clonidine hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 142432 | Clonidine hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 142433 | Hydroxydaunomycin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142433 | Hydroxydaunomycin hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142433 | Hydroxydaunomycin hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 142433 | Hydroxydaunomycin hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 142433 | Hydroxydaunomycin hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142433 | Hydroxydaunomycin hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142434 | Econazole nitrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142434 | Econazole nitrate | Designated preferred name (PT) | YES | |
RxCUI: 142434 | Econazole nitrate | Full form of descriptor (FN) | YES | |
RxCUI: 1424347 | Sierrasil Pain Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1424348 | camphor 31 MG/ML [Sierrasil Pain Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1424349 | camphor Topical Spray [Sierrasil Pain Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 142435 | Ethambutol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142435 | Ethambutol hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142435 | Ethambutol hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 1424350 | Sierrasil Pain Relief Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1424351 | Sierrasil Pain Relief 3.1 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424351 | Sierrasil Pain Relief 3.1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424351 | Sierrasil Pain Relief 3.1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424351 | Sierrasil Pain Relief 3.1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424352 | Kineticream | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1424353 | menthol 20 MG/ML [Kineticream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1424354 | menthol Topical Cream [Kineticream] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1424355 | Kineticream Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1424356 | Kineticream 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424356 | Kineticream 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424356 | Kineticream 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424356 | Kineticream 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424357 | Padina pavonica extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424358 | guaifenesin 250 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424358 | guaifenesin 250 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424359 | Persicaria tinctoria top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 142436 | Fentanyl citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142436 | Fentanyl citrate | Designated preferred name (PT) | YES | |
RxCUI: 142436 | Fentanyl citrate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 142436 | Fentanyl citrate | Full form of descriptor (FN) | YES | |
RxCUI: 1424360 | biosaccharide gum-1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424361 | guaifenesin 100 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424361 | guaifenesin 100 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424362 | guaifenesin 100 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424362 | guaifenesin 100 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424363 | guaifenesin 100 MG / pseudoephedrine hydrochloride 30 MG / theophylline 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424363 | guaifenesin 100 MG / pseudoephedrine hydrochloride 30 MG / theophylline 100 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424364 | dextromethorphan hydrobromide 60 MG / guaifenesin 600 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424364 | dextromethorphan hydrobromide 60 MG / guaifenesin 600 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424365 | dextromethorphan hydrobromide 60 MG / guaifenesin 600 MG / pseudoephedrine hydrochloride 30 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424365 | dextromethorphan hydrobromide 60 MG / guaifenesin 600 MG / pseudoephedrine hydrochloride 30 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424366 | dextromethorphan hydrobromide 30 MG / guaifenesin 580 MG / pseudoephedrine hydrochloride 30 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424366 | dextromethorphan hydrobromide 30 MG / guaifenesin 580 MG / pseudoephedrine hydrochloride 30 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424367 | dextromethorphan hydrobromide 30 MG / guaifenesin 580 MG / pseudoephedrine hydrochloride 30 MG 12 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424367 | dextromethorphan hydrobromide 30 MG / guaifenesin 580 MG / pseudoephedrine hydrochloride 30 MG 12 HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424367 | dextromethorphan hydrobromide 30 MG / guaifenesin 580 MG / pseudoephedrine hydrochloride 30 MG 12 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424367 | dextromethorphan hydrobromide 30 MG / guaifenesin 580 MG / pseudoephedrine hydrochloride 30 MG 12 HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424369 | dextromethorphan hydrobromide 15 MG / pseudoephedrine hydrochloride 30 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 142437 | Flavoxate hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142437 | Flavoxate hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142437 | Flavoxate hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 142437 | Flavoxate hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 1424370 | chlorpheniramine maleate 2 MG / guaifenesin 100 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424370 | chlorpheniramine maleate 2 MG / guaifenesin 100 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424371 | chlorpheniramine maleate 1 MG/ML / pseudoephedrine hydrochloride 30 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424372 | APAP 500 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424372 | APAP 500 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424373 | APAP 500 MG / dextromethorphan hydrobromide 15 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424373 | APAP 500 MG / dextromethorphan hydrobromide 15 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424374 | chlorpheniramine maleate 12 MG / methscopolamine nitrate 2.5 MG / phenylephrine HCl 12HR 20 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424374 | chlorpheniramine maleate 12 MG / methscopolamine nitrate 2.5 MG / phenylephrine HCl 12HR 20 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424375 | APAP 325 MG / dextromethorphan hydrobromide 10 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424375 | APAP 325 MG / dextromethorphan hydrobromide 10 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424376 | APAP 325 MG / caffeine 30 MG / chlorpheniramine maleate 2 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424376 | APAP 325 MG / caffeine 30 MG / chlorpheniramine maleate 2 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424377 | APAP 250 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424377 | APAP 250 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424378 | APAP 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424378 | APAP 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424379 | carbinoxamine maleate 4 MG / guaifenesin 100 MG / pseudoephedrine hydrochloride 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424379 | carbinoxamine maleate 4 MG / guaifenesin 100 MG / pseudoephedrine hydrochloride 60 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424380 | carbinoxamine maleate 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424381 | carbinoxamine maleate 2.5 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424382 | carbinoxamine maleate 2.5 MG / pseudoephedrine hydrochloride 60 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424383 | pseudoephedrine hydrochloride 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424384 | pseudoephedrine hydrochloride 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424385 | tripelennamine hydrochloride 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424386 | pseudoephedrine hydrochloride 60 MG / tripelennamine hydrochloride 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424387 | pseudoephedrine hydrochloride 60 MG / terfenadine 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424388 | promethazine hydrochloride 6.25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424389 | guaiFENesin 600 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424389 | guaiFENesin 600 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424389 | guaiFENesin 600 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 142439 | Dihydrocodeinone bitartrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142439 | Dihydrocodeinone bitartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142439 | Dihydrocodeinone bitartrate | Designated preferred name (PT) | YES | |
RxCUI: 142439 | Dihydrocodeinone bitartrate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 142439 | Dihydrocodeinone bitartrate | Full form of descriptor (FN) | YES | |
RxCUI: 142440 | Lignocaine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142440 | Lignocaine hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142440 | Lignocaine hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 142440 | Lignocaine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142441 | Midazolam maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 142441 | Midazolam maleate | Designated preferred name (PT) | NO | |
RxCUI: 142441 | Midazolam maleate | Full form of descriptor (FN) | NO | |
RxCUI: 142442 | Naproxen sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142442 | Naproxen sodium | Designated preferred name (PT) | YES | |
RxCUI: 142442 | Naproxen sodium | Full form of descriptor (FN) | YES | |
RxCUI: 142443 | Procyclidine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 142443 | Procyclidine hydrochloride | Designated preferred name (PT) | NO | |
RxCUI: 142443 | Procyclidine hydrochloride | Full form of descriptor (FN) | NO | |
RxCUI: 142444 | Promazine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 142444 | Promazine hydrochloride | Designated preferred name (PT) | NO | |
RxCUI: 142444 | Promazine hydrochloride | Full form of descriptor (FN) | NO | |
RxCUI: 142445 | Promethazine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142445 | Promethazine hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142445 | Promethazine hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 1424454 | tretinoin 0.75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1424455 | tretinoin 0.075 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424455 | tretinoin 0.075 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424455 | tretinoin 0.075 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424456 | tretinoin 0.75 MG/ML [Tretin X] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1424457 | TRETIN-X 0.075 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424457 | TRETIN-X 0.075 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424457 | TRETIN-X 0.075 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1424457 | TRETIN-X 0.075 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424458 | C9-11 pareth-8 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424459 | palmitoyl lysyldioxymethionyllysine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 142446 | Tetracycline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142446 | Tetracycline hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 142446 | Tetracycline hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 1424460 | sodium cocoyl glycinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1424461 | cocoyl glycinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424462 | Thaumatococcus daniellii fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 142447 | Ticarcillin sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142447 | Ticarcillin sodium | Designated preferred name (PT) | YES | |
RxCUI: 142447 | Ticarcillin sodium | Full form of descriptor (FN) | YES | |
RxCUI: 142447 | Ticarcillin sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 142448 | liothyronine sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 142448 | liothyronine sodium | Designated preferred name (PT) | YES | |
RxCUI: 142448 | liothyronine sodium | Full form of descriptor (FN) | YES | |
RxCUI: 142449 | Lututrin | Designated preferred name (PT) | NO | |
RxCUI: 142449 | Lututrin | Full form of descriptor (FN) | NO | |
RxCUI: 142449 | Lututrin | Designated preferred name (PT) | NO | |
RxCUI: 142449 | Lututrin | Full form of descriptor (FN) | NO | |
RxCUI: 1424549 | menthol 0.0017 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424550 | menthol 0.17 % / zinc oxide 1.1 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424550 | menthol 0.17 % / zinc oxide 1.1 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424550 | menthol 0.17 % / zinc oxide 1.1 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424550 | menthol 0.17 % / zinc oxide 1.1 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424551 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 5 MG Oral Tablet) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 1424551 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 5 MG Oral Tablet) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1424551 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 5 MG Oral Tablet) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424551 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 5 MG Oral Tablet) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424551 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 5 MG Oral Tablet) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1424553 | peppermint oil 0.001 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424554 | sage oil 0.0002 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424555 | peppermint oil / sage oil Dental Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1424556 | peppermint oil / sage oil Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1424557 | peppermint oil / sage oil Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1424558 | peppermint oil / sage oil Toothpaste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1424559 | peppermint oil / sage oil Toothpaste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1424560 | peppermint oil / sage oil | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1424561 | peppermint oil 0.1 % / sage oil 0.02 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424561 | peppermint oil 0.1 % / sage oil 0.02 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424561 | peppermint oil 0.1 % / sage oil 0.02 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424562 | poly(lactide) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424601 | Pur-Wash | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1424602 | water 983 MG/ML [Pur-Wash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1424603 | water Ophthalmic Irrigation Solution [Pur-Wash] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1424604 | Pur-Wash Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1424605 | Pur-Wash 98.3 % Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424605 | Pur-Wash 98.3 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424605 | Pur-Wash 98.3 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424605 | Pur-Wash 98.3 % Ophthalmic Irrigation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424607 | PsoCleer | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1424608 | salicylic acid 20 MG/ML [PsoCleer] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1424609 | salicylic acid Topical Cream [PsoCleer] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1424610 | PsoCleer Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1424611 | PsoCleer 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424611 | PsoCleer 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424611 | PsoCleer 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424611 | PsoCleer 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1424612 | salicylic acid 40 % Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424612 | salicylic acid 40 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424612 | salicylic acid 40 % Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424612 | salicylic acid 40 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424613 | menthol 8.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1424614 | menthol 8.3 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1424614 | menthol 8.3 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424644 | coceth-7 carboxylic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424645 | purslane extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424646 | phthalocyanine blue | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424646 | phthalocyanine blue | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424647 | alpha-glucan oligosaccharide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424648 | tocotrienol, alpha | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424649 | naproxen 250 MG / pseudoephedrine hydrochloride 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424650 | beta-citronellol, (+-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424651 | beta-d-galactopyranose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424652 | gamma-decalactone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424652 | gamma-decalactone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424653 | guaifenesin 400 MG / pseudoephedrine hydrochloride 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424653 | guaifenesin 400 MG / pseudoephedrine hydrochloride 60 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424654 | guaifenesin 300 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424654 | guaifenesin 300 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424655 | 1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424656 | 1,2-dioleoyl-sn-glycero-3-phosphocholine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424657 | guaifenesin 200 MG / pseudoephedrine hydrochloride 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424657 | guaifenesin 200 MG / pseudoephedrine hydrochloride 60 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424658 | 1,2-dipalmitoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424659 | guaifenesin 125 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424659 | guaifenesin 125 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424660 | dextromethorphan hydrobromide 30 MG / guaifenesin 800 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424660 | dextromethorphan hydrobromide 30 MG / guaifenesin 800 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424661 | 1,3-dimethylbutyl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424662 | glyceryl 1,3-dioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424665 | ammonio methacrylate copolymer type A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424666 | chlorpheniramine maleate 6 MG / pseudoephedrine hydrochloride 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424667 | ammonium lauryl sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424668 | anisyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424669 | buteth-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424670 | brompheniramine maleate 4 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424671 | calcium hypophosphite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424672 | C12-20 alkyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424673 | brompheniramine maleate 4 MG / guaifenesin 300 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424673 | brompheniramine maleate 4 MG / guaifenesin 300 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424674 | C20-22 alkyl phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424675 | calteridol calcium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1424676 | calteridol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424677 | ASA 600 MG / promethazine hydrochloride 6.2 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424677 | ASA 600 MG / promethazine hydrochloride 6.2 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424678 | APAP 500 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424678 | APAP 500 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424679 | candelilla wax powder | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424680 | APAP 500 MG / dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424680 | APAP 500 MG / dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424680 | APAP 500 MG / dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424680 | APAP 500 MG / dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1424681 | 12 HR APAP 500 MG / Chlorpheniramine Maleate 4 MG / Pseudoephedrine sulfate 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424681 | 12 HR APAP 500 MG / Chlorpheniramine Maleate 4 MG / Pseudoephedrine sulfate 60 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424681 | 12 HR APAP 500 MG / Chlorpheniramine Maleate 4 MG / Pseudoephedrine sulfate 60 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424682 | APAP 500 MG / Chlorpheniramine Maleate 4 MG / Pseudoephedrine sulfate 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424682 | APAP 500 MG / Chlorpheniramine Maleate 4 MG / Pseudoephedrine sulfate 60 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424683 | APAP 325 MG / chlorpheniramine maleate 4 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424683 | APAP 325 MG / chlorpheniramine maleate 4 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424835 | 5-hydroxytryptophan 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1424836 | 5-hydroxytryptophan 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424836 | 5-hydroxytryptophan 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424836 | 5-hydroxytryptophan 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424836 | 5-hydroxytryptophan 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424847 | chlorpheniramine maleate 4 MG / methscopolamine nitrate 1.25 MG / pseudoephedrine HCl 60 MG 12 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424847 | chlorpheniramine maleate 4 MG / methscopolamine nitrate 1.25 MG / pseudoephedrine HCl 60 MG 12 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424849 | dextromethorphan HBr 30 MG / guaiFENesin 580 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424849 | dextromethorphan HBr 30 MG / guaiFENesin 580 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1424849 | dextromethorphan HBr 30 MG / guaiFENesin 580 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424849 | dextromethorphan HBr 30 MG / guaiFENesin 580 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424849 | dextromethorphan HBr 30 MG / guaiFENesin 580 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1424850 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 1424850 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1424850 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424850 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424850 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1424863 | Adansonia digitata fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424864 | dimethylsilanol hyaluronate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424865 | apple extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424867 | alpha-d-galactosidase enzyme 300 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424867 | alpha-d-galactosidase enzyme 300 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424868 | cholesteryl-behenyl-octyldodecyl lauroyl glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424871 | chlophedianol hydrochloride 24 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1424872 | chlophedianol HCl 24 MG / chlorpheniramine maleate 3.5 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424872 | chlophedianol HCl 24 MG / chlorpheniramine maleate 3.5 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424873 | magnesium palmitate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1424874 | PPG-5-ceteth-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424875 | borate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424876 | citronellal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424877 | Cucumaria frondosa preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424878 | diamond flounder extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424878 | diamond flounder extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424879 | isostearic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1424880 | isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424881 | English walnut shell extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424881 | English walnut shell extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424882 | fluticasone furoate 0.1 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1424883 | vilanterol trifenatate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1424883 | vilanterol trifenatate | Designated preferred name (PT) | YES | |
RxCUI: 1424883 | vilanterol trifenatate | Full form of descriptor (FN) | YES | |
RxCUI: 1424884 | vilanterol | Full form of descriptor (FN) | YES | |
RxCUI: 1424884 | vilanterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424884 | vilanterol | Designated preferred name (PT) | YES | |
RxCUI: 1424884 | vilanterol | Full form of descriptor (FN) | YES | |
RxCUI: 1424884 | vilanterol | Designated preferred name (PT) | YES | |
RxCUI: 1424885 | vilanterol 0.025 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1424886 | fluticasone / vilanterol Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1424886 | fluticasone / vilanterol Inhalant Product | Designated preferred name (PT) | YES | |
RxCUI: 1424886 | fluticasone / vilanterol Inhalant Product | Full form of descriptor (FN) | YES | |
RxCUI: 1424887 | fluticasone / vilanterol Dry Powder Inhaler | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1424888 | fluticasone / vilanterol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1424888 | fluticasone / vilanterol | Designated preferred name (PT) | YES | |
RxCUI: 1424888 | fluticasone / vilanterol | Full form of descriptor (FN) | YES | |
RxCUI: 1424889 | fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424889 | fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424895 | fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1424897 | jujube fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424898 | locust bean gum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424899 | fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424899 | fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424901 | ascorbic acid 53 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1424902 | ascorbic acid 53 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424902 | ascorbic acid 53 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424902 | ascorbic acid 53 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424902 | ascorbic acid 53 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424904 | Mastocarpus stellatus algae extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424904 | Mastocarpus stellatus algae extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424905 | methacrylic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1424906 | methacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424909 | Marrubium vulgare whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1424909 | Marrubium vulgare whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1424910 | high-density polyethylene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424911 | dabrafenib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1424911 | dabrafenib | Designated preferred name (PT) | YES | |
RxCUI: 1424911 | dabrafenib | Full form of descriptor (FN) | YES | |
RxCUI: 1424911 | dabrafenib | Designated preferred name (PT) | YES | |
RxCUI: 1424911 | dabrafenib | Full form of descriptor (FN) | YES | |
RxCUI: 1424912 | dabrafenib 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1424913 | dabrafenib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1424913 | dabrafenib Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 1424913 | dabrafenib Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 1424914 | dabrafenib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1424915 | dabrafenib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1424916 | dabrafenib 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424916 | dabrafenib 50 MG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 1424916 | dabrafenib 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424916 | dabrafenib 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424916 | dabrafenib 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424916 | dabrafenib 50 MG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 1424917 | dabrafenib 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1424918 | dabrafenib 75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424918 | dabrafenib 75 MG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 1424918 | dabrafenib 75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424918 | dabrafenib 75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424918 | dabrafenib 75 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424918 | dabrafenib 75 MG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 1424919 | dextromethorphan HBr 15 MG / guaiFENesin 175 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1424919 | dextromethorphan HBr 15 MG / guaiFENesin 175 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1424919 | dextromethorphan HBr 15 MG / guaiFENesin 175 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1424919 | dextromethorphan HBr 15 MG / guaiFENesin 175 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1424919 | dextromethorphan HBr 15 MG / guaiFENesin 175 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1425 | Benzydamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425 | Benzydamine | Designated preferred name (PT) | NO | |
RxCUI: 1425 | Benzydamine | Full form of descriptor (FN) | NO | |
RxCUI: 1425 | Benzydamine | Designated preferred name (PT) | NO | |
RxCUI: 1425 | Benzydamine | Full form of descriptor (FN) | NO | |
RxCUI: 1425087 | Sandalwood | Designated preferred name (PT) | NO | |
RxCUI: 1425087 | Sandalwood | Full form of descriptor (FN) | NO | |
RxCUI: 1425087 | Sandalwood | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425088 | amino-propyl-triethoxysilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425088 | amino-propyl-triethoxysilane | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425089 | polawax polysorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425090 | glucosamine HCl 750 MG / methylsulfonylmethane 750 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425090 | glucosamine HCl 750 MG / methylsulfonylmethane 750 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425090 | glucosamine HCl 750 MG / methylsulfonylmethane 750 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1425098 | trametinib dimethyl sulfoxide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1425098 | trametinib dimethyl sulfoxide | Designated preferred name (PT) | YES | |
RxCUI: 1425098 | trametinib dimethyl sulfoxide | Full form of descriptor (FN) | YES | |
RxCUI: 1425099 | trametinib | Full form of descriptor (FN) | YES | |
RxCUI: 1425099 | trametinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425099 | trametinib | Designated preferred name (PT) | YES | |
RxCUI: 1425099 | trametinib | Full form of descriptor (FN) | YES | |
RxCUI: 1425099 | trametinib | Designated preferred name (PT) | YES | |
RxCUI: 1425100 | trametinib 0.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1425101 | trametinib Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 1425101 | trametinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1425101 | trametinib Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 1425102 | trametinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1425103 | trametinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1425104 | trametinib 0.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 1425104 | trametinib 0.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 1425104 | trametinib 0.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425104 | trametinib 0.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425104 | trametinib 0.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1425105 | Mekinist | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1425106 | trametinib 0.5 MG [Mekinist] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1425107 | trametinib Oral Tablet [Mekinist] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1425108 | Mekinist Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1425109 | Mekinist Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1425110 | Mekinist 0.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425110 | Mekinist 0.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425110 | Mekinist 0.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425110 | Mekinist 0.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1425111 | trametinib 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1425112 | trametinib 1 MG (as trametinib dimethyl sulfoxide 1.127 MG) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425112 | trametinib 1 MG (as trametinib dimethyl sulfoxide 1.127 MG) Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1425113 | trametinib 1 MG [Mekinist] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425114 | Mekinist 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425114 | Mekinist 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425114 | Mekinist 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425114 | Mekinist 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425115 | trametinib 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1425116 | trametinib 2 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 1425116 | trametinib 2 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 1425116 | trametinib 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425116 | trametinib 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425116 | trametinib 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1425117 | trametinib 2 MG [Mekinist] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1425118 | Mekinist 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425118 | Mekinist 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425118 | Mekinist 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425118 | Mekinist 2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1425119 | melatonin 0.333 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1425120 | melatonin 5 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1425120 | melatonin 5 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425120 | melatonin 5 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425175 | Healthy Mama | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1425176 | calcium carbonate 500 MG [Healthy Mama] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1425177 | calcium carbonate Chewable Tablet [Healthy Mama] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1425178 | Healthy Mama Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1425179 | Healthy Mama Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1425180 | Healthy Mama Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1425181 | Healthy Mama Tame The Flame 500 MG (Ca 200 MG) Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1425181 | Healthy Mama Tame The Flame 500 MG (Ca 200 MG) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425181 | Healthy Mama Tame The Flame 500 MG (Ca 200 MG) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425181 | Healthy Mama Tame The Flame 500 MG (Ca 200 MG) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425214 | caviar preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425215 | cellacefate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425215 | cellacefate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425216 | cellulose acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425216 | cellulose acetate | Designated preferred name (PT) | YES | |
RxCUI: 1425216 | cellulose acetate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425216 | cellulose acetate | Full form of descriptor (FN) | YES | |
RxCUI: 1425217 | ceresin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425218 | cetearyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425219 | cetearyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425220 | ceteth-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425221 | cetyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425222 | Dabrafenib mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425222 | Dabrafenib mesilate | Full form of descriptor (FN) | YES | |
RxCUI: 1425222 | Dabrafenib mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1425222 | Dabrafenib mesilate | Designated preferred name (PT) | YES | |
RxCUI: 1425223 | Tafinlar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1425224 | dabrafenib 50 MG [Tafinlar] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1425225 | dabrafenib Oral Capsule [Tafinlar] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1425226 | Tafinlar Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1425227 | Tafinlar Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1425228 | Tafinlar 50 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1425228 | Tafinlar 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425228 | Tafinlar 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425228 | Tafinlar 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425229 | dabrafenib 75 MG [Tafinlar] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1425230 | Tafinlar 75 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1425230 | Tafinlar 75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425230 | Tafinlar 75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425230 | Tafinlar 75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425312 | chlorpheniramine maleate 6.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1425313 | zinc oxide 18 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1425314 | dimethicone 1.8 % / zinc oxide 1.8 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425314 | dimethicone 1.8 % / zinc oxide 1.8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425314 | dimethicone 1.8 % / zinc oxide 1.8 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1425314 | dimethicone 1.8 % / zinc oxide 1.8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425315 | acetaminophen 325 MG / chlorpheniramine maleate 6.25 MG / dextromethorphan HBr 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425315 | acetaminophen 325 MG / chlorpheniramine maleate 6.25 MG / dextromethorphan HBr 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1425315 | acetaminophen 325 MG / chlorpheniramine maleate 6.25 MG / dextromethorphan HBr 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425316 | Protex Deep Clean | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1425318 | triclocarban Medicated Liquid Soap [Protex Deep Clean] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1425319 | Protex Deep Clean Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425321 | triclocarban 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1425322 | triclocarban 0.4 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425322 | triclocarban 0.4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425322 | triclocarban 0.4 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1425323 | triclocarban 4 MG/ML [Protex Deep Clean] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425324 | Protex 0.4 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425324 | Protex 0.4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425324 | Protex 0.4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425324 | Protex 0.4 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425325 | camphor 3.1 % / menthol 10 % / methyl salicylate 15 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1425325 | camphor 3.1 % / menthol 10 % / methyl salicylate 15 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425325 | camphor 3.1 % / menthol 10 % / methyl salicylate 15 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425331 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / chlorpheniramine maleate 6.25 MG / dextromethorphan HBr 15 MG Oral Tablet) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
RxCUI: 1425331 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / chlorpheniramine maleate 6.25 MG / dextromethorphan HBr 15 MG Oral Tablet) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425331 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / chlorpheniramine maleate 6.25 MG / dextromethorphan HBr 15 MG Oral Tablet) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425332 | Zenzedi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1425333 | dextroamphetamine sulfate 10 MG [Zenzedi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1425334 | dextroamphetamine Oral Tablet [Zenzedi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1425335 | Zenzedi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1425336 | Zenzedi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1425337 | Zenzedi 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1425337 | Zenzedi 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425337 | Zenzedi 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425338 | dextroamphetamine sulfate 5 MG [Zenzedi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1425339 | Zenzedi 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1425339 | Zenzedi 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425339 | Zenzedi 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425340 | glycerin Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1425348 | Tineacide Antifungal Reformulated Jun 2013 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1425349 | miconazole nitrate 20 MG/ML [Tineacide Antifungal Reformulated Jun 2013] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425350 | miconazole Topical Cream [Tineacide Antifungal Reformulated Jun 2013] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1425351 | Tineacide Antifungal Reformulated Jun 2013 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425352 | miconazole nitrate 2 % Topical Cream [Tineacide Antifungal Reformulated Jun 2013] | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425352 | miconazole nitrate 2 % Topical Cream [Tineacide Antifungal Reformulated Jun 2013] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425352 | miconazole nitrate 2 % Topical Cream [Tineacide Antifungal Reformulated Jun 2013] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425352 | miconazole nitrate 2 % Topical Cream [Tineacide Antifungal Reformulated Jun 2013] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425352 | miconazole nitrate 2 % Topical Cream [Tineacide Antifungal Reformulated Jun 2013] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425353 | galactoarabinan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425354 | palmitostearic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425354 | palmitostearic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425355 | potassium cocoyl glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1425356 | Salvia sclarea seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425357 | sodium laurate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1425403 | Yucca schidigera whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425403 | Yucca schidigera whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425404 | Verbena officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425404 | Verbena officinalis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425405 | N-valyltryptophan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425406 | myristyl nicotinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425407 | ethanol 72 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1425407 | ethanol 72 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425407 | ethanol 72 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425412 | Helianthus annuus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425413 | Elaeis guineensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425414 | Super 2X | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1425415 | chlorhexidine gluconate 10 MG/ML [Super 2X] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425416 | chlorhexidine Topical Solution [Super 2X] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1425417 | Super 2X Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425418 | SUPER 2X 1 % CHG Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425418 | SUPER 2X 1 % CHG Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425418 | SUPER 2X 1 % CHG Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425418 | SUPER 2X 1 % CHG Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425419 | choline C 11 | Designated preferred name (PT) | YES | |
RxCUI: 1425419 | choline C 11 | Full form of descriptor (FN) | YES | |
RxCUI: 1425419 | choline C 11 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425419 | choline C 11 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1425426 | Choline chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1425426 | Choline chloride | Designated preferred name (PT) | YES | |
RxCUI: 1425426 | Choline chloride | Full form of descriptor (FN) | YES | |
RxCUI: 1425427 | IR DIP 10 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1425428 | hydrogen peroxide 10 MG/ML [IR DIP 10] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425429 | hydrogen peroxide Topical Solution [IR DIP 10] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1425430 | IR DIP 10 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425431 | IR DIP 10 1 % Iodine Replacement Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425431 | IR DIP 10 1 % Iodine Replacement Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425431 | IR DIP 10 1 % Iodine Replacement Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425431 | IR DIP 10 1 % Iodine Replacement Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425442 | HP 502 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1425443 | hydrogen peroxide 5 MG/ML [HP 502] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425444 | hydrogen peroxide Topical Solution [HP 502] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1425445 | HP 502 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425446 | HP 502 0.5 % Hydrogen Peroxide Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425446 | HP 502 0.5 % Hydrogen Peroxide Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425446 | HP 502 0.5 % Hydrogen Peroxide Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425446 | HP 502 0.5 % Hydrogen Peroxide Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425447 | hydrogen peroxide 8.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1425448 | hydrogen peroxide 0.85 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425448 | hydrogen peroxide 0.85 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425448 | hydrogen peroxide 0.85 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1425489 | Hexidip | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1425490 | chlorhexidine gluconate 5 MG/ML [Hexidip] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425491 | chlorhexidine Topical Solution [Hexidip] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1425492 | Hexidip Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425493 | Hexidip 0.5 % Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425493 | Hexidip 0.5 % Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425493 | Hexidip 0.5 % Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425493 | Hexidip 0.5 % Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425494 | IO-SANS 110 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1425495 | hydrogen peroxide 10 MG/ML [IO-SANS 110] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425496 | hydrogen peroxide Topical Solution [IO-SANS 110] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1425497 | IO-SANS 110 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425498 | IO-SANS 110, 1 % Iodine Replacement Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425498 | IO-SANS 110, 1 % Iodine Replacement Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425498 | IO-SANS 110, 1 % Iodine Replacement Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425498 | IO-SANS 110, 1 % Iodine Replacement Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425501 | cochineal stain | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425501 | cochineal stain | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425503 | coco glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425504 | FD&C blue #10 aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425505 | FD&C blue #2 HT aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425506 | LidoPro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1425507 | capsaicin 0.000325 MG/MG / lidocaine 0.045 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG [LidoPro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425508 | capsaicin / lidocaine / menthol / methyl salicylate Topical Ointment [LidoPro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1425509 | LidoPro Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1425510 | LidoPro 0.0325 % / 4.5 % / 10 % / 27.5 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425510 | LidoPro 0.0325 % / 4.5 % / 10 % / 27.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425510 | LidoPro 0.0325 % / 4.5 % / 10 % / 27.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425554 | Stridex 2 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1425554 | Stridex 2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425554 | Stridex 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425554 | Stridex 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425555 | sodium bicarbonate 0.298 MEQ/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1425556 | sodium bicarbonate Dental Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1425557 | sodium bicarbonate Mouthwash Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1425558 | sodium bicarbonate Mouthwash | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1425559 | sodium bicarbonate 2.5 % Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425559 | sodium bicarbonate 2.5 % Oral Rinse | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1425559 | sodium bicarbonate 2.5 % Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425559 | sodium bicarbonate 2.5 % Oral Rinse | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425615 | Citrus limon seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425847 | dextroamphetamine sulfate 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425847 | dextroamphetamine sulfate 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1425854 | dextroamphetamine sulfate 7.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425854 | dextroamphetamine sulfate 7.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1425857 | Iampur | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1425858 | camphor 40 MG/ML / menthol 40 MG/ML / methyl salicylate 110 MG/ML [Iampur] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425859 | camphor / menthol / methyl salicylate Topical Cream [Iampur] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1425860 | Iampur Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425861 | Iampur Camphor 4 % / Menthol 4 % / methyl salicylate 11 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425861 | Iampur Camphor 4 % / Menthol 4 % / methyl salicylate 11 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425861 | Iampur Camphor 4 % / Menthol 4 % / methyl salicylate 11 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425862 | MacerRx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1425863 | miconazole nitrate 20 MG/ML [MacerRx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425864 | miconazole Topical Cream [MacerRx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1425865 | MacerRx Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425866 | MacerRx 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425866 | MacerRx 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425866 | MacerRx 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425866 | MacerRx 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425867 | potassium nitrate 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1425868 | potassium nitrate Oral Paste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1425869 | potassium nitrate 5 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425869 | potassium nitrate 5 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425869 | potassium nitrate 5 % Oral Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425869 | potassium nitrate 5 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425869 | potassium nitrate 5 % Oral Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1425870 | Res-Q-Dent | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1425871 | potassium nitrate 50 MG/ML [Res-Q-Dent] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425872 | potassium nitrate Oral Paste [Res-Q-Dent] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1425873 | Res-Q-Dent Oral Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425874 | Res-Q-Dent Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425875 | Res-Q-Dent Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425876 | RES-Q-DENT 5 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425876 | RES-Q-DENT 5 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425876 | RES-Q-DENT 5 % Oral Paste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425876 | RES-Q-DENT 5 % Oral Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425876 | RES-Q-DENT 5 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425876 | RES-Q-DENT 5 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425878 | pullulan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425879 | pyroxylin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425879 | pyroxylin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425900 | Rosa canina flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425901 | Aphloia theiformis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425909 | caprylic-capric diglycerol succinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425910 | calamine 0.02 MG/MG / menthol 0.0045 MG/MG / zinc oxide 0.18 MG/MG [Lantiseptic Multi-Purpose] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1425911 | calamine / menthol / zinc oxide Topical Ointment [Lantiseptic Multi-Purpose] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1425912 | Lantiseptic Multi-Purpose 2 % / 0.45 % / 18 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1425912 | Lantiseptic Multi-Purpose 2 % / 0.45 % / 18 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425912 | Lantiseptic Multi-Purpose 2 % / 0.45 % / 18 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425912 | Lantiseptic Multi-Purpose 2 % / 0.45 % / 18 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1425913 | FD&C red #40 HT aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425915 | FD&C yellow #5 aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425918 | magnesium ascorbyl phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1425919 | montmorrillonite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425923 | myristyl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425924 | myristyl myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425926 | modified corn starch (1-octenyl succinic anhydride) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425927 | Tropaeolum majus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425927 | Tropaeolum majus whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425932 | talactoferrin alpha | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1425932 | talactoferrin alpha | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425933 | Lactotransferrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425933 | Lactotransferrin | Designated preferred name (PT) | NO | |
RxCUI: 1425933 | Lactotransferrin | Full form of descriptor (FN) | NO | |
RxCUI: 1425933 | Lactotransferrin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425936 | Phormidium persicinum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425941 | myristyl-gamma-picolinium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1425941 | myristyl-gamma-picolinium chloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425941 | myristyl-gamma-picolinium chloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1425949 | guaifenesin 1200 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1425949 | guaifenesin 1200 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1425974 | Opticlear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1425975 | water 985 MG/ML [Opticlear] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1425976 | water Ophthalmic Irrigation Solution [Opticlear] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1425977 | Opticlear Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1425978 | Opticlear 98.5 % Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1425978 | Opticlear 98.5 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425978 | Opticlear 98.5 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1425978 | Opticlear 98.5 % Ophthalmic Irrigation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1425981 | benzalkonium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1425982 | C20-40 acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425983 | didecyldimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1425983 | didecyldimonium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426 | Benzyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426 | Benzyl alcohol | Designated preferred name (PT) | YES | |
RxCUI: 1426 | Benzyl alcohol | Full form of descriptor (FN) | YES | |
RxCUI: 1426 | Benzyl alcohol | Designated preferred name (PT) | YES | |
RxCUI: 1426 | Benzyl alcohol | Full form of descriptor (FN) | YES | |
RxCUI: 1426141 | menthol 1.25 % / methyl salicylate 31 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426141 | menthol 1.25 % / methyl salicylate 31 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426141 | menthol 1.25 % / methyl salicylate 31 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426141 | menthol 1.25 % / methyl salicylate 31 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1426147 | Valtrum Sport | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1426149 | camphor / menthol / methyl salicylate Topical Spray [Valtrum Sport] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1426150 | Valtrum Sport Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1426152 | potassium nitrate 5 % / sodium monofluorophosphate 0.76 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426152 | potassium nitrate 5 % / sodium monofluorophosphate 0.76 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426152 | potassium nitrate 5 % / sodium monofluorophosphate 0.76 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1426152 | potassium nitrate 5 % / sodium monofluorophosphate 0.76 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426152 | potassium nitrate 5 % / sodium monofluorophosphate 0.76 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426153 | Ketacine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1426154 | ketamine 100 MG/ML [Ketacine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1426155 | ketamine Injectable Solution [Ketacine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1426156 | Ketacine Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1426157 | ketamine 100 MG/ML Injectable Solution [Ketacine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426157 | ketamine 100 MG/ML Injectable Solution [Ketacine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426157 | ketamine 100 MG/ML Injectable Solution [Ketacine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426157 | ketamine 100 MG/ML Injectable Solution [Ketacine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1426158 | Grindelia squarrosa flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426159 | di-PPG-2 myreth-10 adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426160 | PEG-175 diisostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426161 | pigment red 48 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426162 | ethyl lauroyl arginate hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426163 | ethyl lauroyl arginate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426164 | factor VII, human | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426165 | protein S human | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426165 | protein S human | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426166 | coagulation factor X, human | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426250 | dextroamphetamine sulfate 2.5 MG [Zenzedi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1426251 | Zenzedi 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1426251 | Zenzedi 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1426251 | Zenzedi 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426252 | dextroamphetamine sulfate 7.5 MG [Zenzedi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1426253 | Zenzedi 7.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1426253 | Zenzedi 7.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1426253 | Zenzedi 7.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426254 | oleanolic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426255 | glycol stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426256 | Pain Goodbye | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1426257 | menthol 50 MG/ML [Pain Goodbye] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1426258 | menthol Topical Cream [Pain Goodbye] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1426259 | Pain Goodbye Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1426260 | Pain Goodbye 5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1426260 | Pain Goodbye 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426260 | Pain Goodbye 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426260 | Pain Goodbye 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426261 | jasmine lactone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426263 | gentian violet 0.01 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1426265 | acriflavine / gentian violet / sodium propionate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1426266 | acriflavine / gentian violet / sodium propionate Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1426267 | acriflavine / gentian violet / sodium propionate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1426269 | Blu-Kote | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1426271 | acriflavine / gentian violet / sodium propionate Topical Spray [Blu-Kote] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1426272 | Blu-Kote Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1426274 | acriflavine 0.0015 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1426275 | sodium propionate 0.091 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1426276 | acriflavine 0.15 % / gentian violet 1 % / sodium propionate 9.1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1426276 | acriflavine 0.15 % / gentian violet 1 % / sodium propionate 9.1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426276 | acriflavine 0.15 % / gentian violet 1 % / sodium propionate 9.1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426277 | acriflavine 0.0015 MG/ML / gentian violet 0.01 MG/ML / sodium propionate 0.091 MG/ML [Blu-Kote] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1426278 | BLU-KOTE 9.1 % / 1 % / 0.15 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1426278 | BLU-KOTE 9.1 % / 1 % / 0.15 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426278 | BLU-KOTE 9.1 % / 1 % / 0.15 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426280 | zinc pidolate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426288 | norethindrone acetate 1 MG / ethinyl estradiol 20 MCG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1426288 | norethindrone acetate 1 MG / ethinyl estradiol 20 MCG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426288 | norethindrone acetate 1 MG / ethinyl estradiol 20 MCG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1426289 | tridecyl trimellitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426290 | hypromellose acetate succinate 12070923 (3 MM2-S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426291 | benzocaine Topical Ointment [Americaine Hemorrhoidal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1426292 | Americaine Hemorrhoidal Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1426293 | Americaine Hemorrhoidal 20 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426293 | Americaine Hemorrhoidal 20 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1426293 | Americaine Hemorrhoidal 20 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426293 | Americaine Hemorrhoidal 20 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1426329 | magnesium aluminometasilicate type I-A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426330 | maleic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426331 | maleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426332 | mangifera indica (mango) fruit extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426332 | mangifera indica (mango) fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426333 | phenethyl benzoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426334 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426334 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1426334 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426335 | phenoxyacetic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426336 | phenoxyacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426339 | polifeprosan 20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426343 | saccharomyces lysate extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426352 | steareth-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426353 | stearic monoethanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426355 | stearyl heptanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426360 | stearyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426364 | tangerine extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426365 | trideceth-6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426368 | triisopropanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426372 | octadecyl trimethyl ammonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426373 | octadecyltrimethylammonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426374 | glyceryl 1-oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426374 | glyceryl 1-oleate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426375 | hydatid worm preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426375 | hydatid worm preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426376 | 3-hexenyl acetate, cis- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426376 | 3-hexenyl acetate, cis- | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426377 | Taenia saginata preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426378 | aceglutamide aluminum | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426379 | aceglutamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426380 | octyl palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426380 | octyl palmitate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426381 | Bovine serum albumin | Designated preferred name (PT) | YES | |
RxCUI: 1426381 | Bovine serum albumin | Full form of descriptor (FN) | YES | |
RxCUI: 1426381 | Bovine serum albumin | Designated preferred name (PT) | YES | |
RxCUI: 1426381 | Bovine serum albumin | Full form of descriptor (FN) | YES | |
RxCUI: 1426381 | Bovine serum albumin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426382 | Haematococcus pluvialis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426383 | Himanthalia elongata extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426384 | C12-20 alkyl benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426385 | C18-36 acid triglyceride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426386 | tribehenin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426387 | methanesulfonic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426388 | mesylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426389 | Scleromitrion diffusum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426389 | Scleromitrion diffusum extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426390 | Aliphatic carboxylic acid, C16:0 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426390 | Aliphatic carboxylic acid, C16:0 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426390 | Aliphatic carboxylic acid, C16:0 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426390 | Aliphatic carboxylic acid, C16:0 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426390 | Aliphatic carboxylic acid, C16:0 | Designated preferred name (PT) | YES | |
RxCUI: 1426390 | Aliphatic carboxylic acid, C16:0 | Full form of descriptor (FN) | YES | |
RxCUI: 1426391 | diacetyl benzoyl lathyrol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426392 | diethylamino hydroxybenzoyl hexyl benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426393 | coco monoethanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426394 | polyquaternium-7 (70-30 acrylamide-DADMAC 1600000 MW) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426394 | polyquaternium-7 (70-30 acrylamide-DADMAC 1600000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426395 | octoxynol-40 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426396 | sea scallop preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426397 | sorbitan tristearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426398 | octoxynol-5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426399 | zinc laurate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426400 | pongamol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426401 | cystamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426402 | octyldecanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426403 | low-density polyethylene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426404 | lauroyl lysine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426405 | polysorbate 65 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426406 | pentaerythrityl tetraethylhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426407 | PPG-2 myristyl ether propionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426408 | polyoxyl-10 oleyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426408 | polyoxyl-10 oleyl ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426409 | zinc methionine sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426410 | oleth-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426411 | glyceryl stearate citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426412 | polyisobutylene (1200000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426412 | polyisobutylene (1200000 MW) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426413 | lactobionic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426414 | lactobionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426415 | aluminum starch octenylsuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426416 | channel wrack extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426416 | channel wrack extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426417 | dimethicone 1000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426418 | hydrogenated soybean lecithin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426419 | white nettle extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426419 | white nettle extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426419 | white nettle extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426420 | Loxosceles reclusa preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426421 | Pimpinella anisum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426421 | Pimpinella anisum whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426422 | Ext. D&C violet no. 2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426422 | Ext. D&C violet no. 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426423 | Zizyphus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426423 | Zizyphus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426424 | hydrolyzed wheat protein (enzymatic, 3000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426425 | synthetic wax (1200 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426426 | polyisobutylene (1300 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426427 | oleyl oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426428 | polyglycerin-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426429 | polymethylsilsesquioxane (11 microns) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426430 | polymethylsilsesquioxane (4.5 microns) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426431 | Macrocystis pyrifera extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426432 | polyoxyl 40 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426433 | potassium bisulfite | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426435 | PEG-50 hydrogenated castor oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426435 | PEG-50 hydrogenated castor oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426436 | horehound extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426437 | cod, unspecified preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426438 | edible oyster preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426439 | European flounder preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426441 | Canarium luzonicum extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426441 | Canarium luzonicum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426442 | ferric ammonium ferrocyanide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426443 | calcium peroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426444 | calcium phosphate, monobasic, anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426445 | potassium cocoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426446 | potassium polymetaphosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426446 | potassium polymetaphosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426447 | alpha-tocopherol succinate, D- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426448 | ceramide NG | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426448 | ceramide NG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426449 | Micrococcus luteus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426450 | Mesophyllum lichenoides extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426451 | kojic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426452 | isostearamidopropyl morpholine lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426453 | calcium propionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426454 | IgA - Immunoglobulin A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426454 | IgA - Immunoglobulin A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426454 | IgA - Immunoglobulin A | Designated preferred name (PT) | NO | |
RxCUI: 1426454 | IgA - Immunoglobulin A | Full form of descriptor (FN) | NO | |
RxCUI: 1426455 | coco-glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426456 | ethylene-vinyl acetate copolymer (28% vinyl acetate) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426457 | ethyl acrylate and methyl methacrylate copolymer (2:1; 750000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426458 | ioxaglic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426459 | linoleamidopropyl PG-dimonium chloride phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426460 | D&C blue no. 4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426462 | N-acetyl-methionine, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426463 | N-acetylmethionine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426464 | D&C green no. 8 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426465 | Transforming growth factor beta 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426465 | Transforming growth factor beta 1 | Designated preferred name (PT) | NO | |
RxCUI: 1426465 | Transforming growth factor beta 1 | Full form of descriptor (FN) | NO | |
RxCUI: 1426466 | Dunaliella salina extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426467 | iodopropynyl butylcarbamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426467 | iodopropynyl butylcarbamate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426468 | D&C orange no. 4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426469 | anti-interleukin-1.alpha. immunoglobulin G rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426470 | Dichlorofluoromethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426470 | Dichlorofluoromethane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426470 | Dichlorofluoromethane | Designated preferred name (PT) | NO | |
RxCUI: 1426470 | Dichlorofluoromethane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426470 | Dichlorofluoromethane | Full form of descriptor (FN) | NO | |
RxCUI: 1426470 | Dichlorofluoromethane | Designated preferred name (PT) | NO | |
RxCUI: 1426470 | Dichlorofluoromethane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426470 | Dichlorofluoromethane | Full form of descriptor (FN) | NO | |
RxCUI: 1426471 | hexanoyl dipeptide-3 norleucine acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426472 | D&C red no. 17 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426472 | D&C red no. 17 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426473 | lime extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426474 | acetylated monoglycerides | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426474 | acetylated monoglycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426475 | diethyl sebacate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426475 | diethyl sebacate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426476 | limonene, (+)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426477 | limonene, (+/-)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426478 | lanolin alcohols | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426479 | menthone 1,2-glycerol ketal, (-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426480 | liquefied petroleum gas | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426481 | Clonostachys rosea f. rosea allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426482 | N-cholylglycine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426482 | N-cholylglycine | Designated preferred name (PT) | NO | |
RxCUI: 1426482 | N-cholylglycine | Full form of descriptor (FN) | NO | |
RxCUI: 1426482 | N-cholylglycine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426483 | cholate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426558 | Laminaria japonica extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426559 | Laminaria ochroleuca extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426560 | Sani-Hands Basics | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1426561 | benzalkonium chloride 1.3 MG/ML [Sani-Hands Basics] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1426562 | benzalkonium Medicated Pad [Sani-Hands Basics] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1426563 | Sani-Hands Basics Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1426564 | Sani-Hands Basics Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1426565 | Sani-Hands Basics 0.13 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1426565 | Sani-Hands Basics 0.13 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426565 | Sani-Hands Basics 0.13 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426565 | Sani-Hands Basics 0.13 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426565 | Sani-Hands Basics 0.13 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426569 | Prostamate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1426570 | dinoprost 5 MG/ML [Prostamate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1426571 | dinoprost Injectable Solution [Prostamate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1426572 | Prostamate Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1426573 | ProstaMate 5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426573 | ProstaMate 5 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1426573 | ProstaMate 5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426573 | ProstaMate 5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426574 | Ovacyst | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1426575 | gonadorelin 0.05 MG/ML [Ovacyst] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1426576 | gonadorelin Injectable Solution [Ovacyst] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1426577 | Ovacyst Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1426578 | OvaCyst 0.05 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426578 | OvaCyst 0.05 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1426578 | OvaCyst 0.05 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426578 | OvaCyst 0.05 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426579 | guaiFENesin 380 MG / pseudoephedrine HCl 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1426579 | guaiFENesin 380 MG / pseudoephedrine HCl 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1426579 | guaiFENesin 380 MG / pseudoephedrine HCl 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1426593 | lidocaine / phenol Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1426594 | lidocaine HCl 0.5 % / phenol 0.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426594 | lidocaine HCl 0.5 % / phenol 0.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426594 | lidocaine HCl 0.5 % / phenol 0.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1426595 | p-anisic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426595 | p-anisic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426596 | palmitoyl pentapeptide-3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426596 | palmitoyl pentapeptide-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426597 | panthenol triacetate, (+)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426598 | sulfate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426599 | dimethyl isosorbide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426600 | Eth estra-Noreth Ac 0.02-1 MG (24) Chewable Tablet / Ferr fum 75 MG (4) Oral Tablet 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 1426600 | Eth estra-Noreth Ac 0.02-1 MG (24) Chewable Tablet / Ferr fum 75 MG (4) Oral Tablet 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1426601 | Minastrin 24 Fe Chewable 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1426601 | Minastrin 24 Fe Chewable 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1426601 | Minastrin 24 Fe Chewable 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426602 | Pore Rescue | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1426603 | salicylic acid 0.01 MG/MG [Pore Rescue] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1426604 | salicylic acid Topical Gel [Pore Rescue] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1426605 | Pore Rescue Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1426606 | BIOELEMENTS Pore Rescue Acne Gel 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426606 | BIOELEMENTS Pore Rescue Acne Gel 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426606 | BIOELEMENTS Pore Rescue Acne Gel 1 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1426606 | BIOELEMENTS Pore Rescue Acne Gel 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426607 | dipentaerythrityl hexacaprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426608 | betadex sulfobutyl ether sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426608 | betadex sulfobutyl ether sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426609 | cyclodextrins | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426610 | PEG-PPG-18-18-dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426611 | modified corn starch (3-E-docecenyl succinic anhydride) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426612 | diethylaminoethyl-dextran hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426613 | diethylaminoethyl-dextran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426614 | triclocarban 0.003 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1426615 | triclocarban 0.3 % Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1426615 | triclocarban 0.3 % Medicated Bar Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426615 | triclocarban 0.3 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426616 | triclocarban 0.003 MG/MG [Dial Antibacterial] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1426617 | Dial Antibacterial 0.3 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426617 | Dial Antibacterial 0.3 % Medicated Bar Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426617 | Dial Antibacterial 0.3 % Medicated Bar Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1426617 | Dial Antibacterial 0.3 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426619 | propylene glycol dicaprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426620 | propylene glycol diethylhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426621 | hydroxyisohexyl 3-cyclohexene carboxaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426622 | propylene glycol dicaprylate-dicaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426623 | isopropyl maleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426624 | palm acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426625 | dimethyloctadecyl(3-(trimethoxysilyl)propyl)ammonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426626 | palm kernel acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426627 | sodium methylesculetin acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426628 | methylesculetin acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426629 | Thermomyces lanuginosus allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426630 | glycereth-26 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426631 | rinfabate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426632 | slippery elm pollen allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426632 | slippery elm pollen allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426634 | Serratia marcescens | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426635 | Stypocaulon scoparium preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426636 | lutrelin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426644 | ectoine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426645 | guava extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426646 | silica dimethyl silylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426647 | ammonium cocoyl isethionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426649 | polyquaternium-39 (35-35-30 acrylic acid-acrylamide-dadmac; 1500000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426654 | polyquaternium-11 (1000000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426658 | potassium pyrophosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426660 | dextromethorphan HBr 15 MG / guaiFENesin 400 MG / pseudoephedrine HCl 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1426660 | dextromethorphan HBr 15 MG / guaiFENesin 400 MG / pseudoephedrine HCl 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1426660 | dextromethorphan HBr 15 MG / guaiFENesin 400 MG / pseudoephedrine HCl 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1426661 | beard lichen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426661 | beard lichen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426662 | triisostearin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426663 | liquid petroleum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426664 | dimethicone 200 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426665 | Trichosporon cutaneum allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426666 | Penicillium brevicompactum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426667 | Avicularia avicularia preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426670 | Vespa crabro preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426671 | undecylenoyl glycine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426672 | PEG-PPG-20-20 dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426673 | PEG-PPG-14-4 dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426675 | synthetic wax (1800 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426676 | trimethylsiloxysilicate (M-Q 0.8-1.0) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426677 | trimethylsiloxysilicate (M-Q 0.6-0.8) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426678 | C12-14 pareth-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426679 | Yersinia enterocolitica | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426680 | Human immunoglobulin G | Designated preferred name (PT) | YES | |
RxCUI: 1426680 | Human immunoglobulin G | Full form of descriptor (FN) | YES | |
RxCUI: 1426680 | Human immunoglobulin G | Designated preferred name (PT) | YES | |
RxCUI: 1426680 | Human immunoglobulin G | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426680 | Human immunoglobulin G | Full form of descriptor (FN) | YES | |
RxCUI: 1426681 | levocarnitine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426681 | levocarnitine hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1426682 | binetrakin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426686 | benzocaine / cetylpyridinium / menthol Mucosal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1426687 | benzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.5 % Mucosal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1426687 | benzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.5 % Mucosal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426687 | benzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.5 % Mucosal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1426688 | hyaluronic acid 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1426689 | methylsulfonylmethane 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1426690 | chondroitin sulfates / glucosamine / hyaluronate / methylsulfonylmethane Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1426691 | chondroitin sulfates / glucosamine / hyaluronate / methylsulfonylmethane Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1426692 | chondroitin sulfates / glucosamine / hyaluronate / methylsulfonylmethane Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1426693 | chondroitin sulfates / glucosamine / hyaluronate / methylsulfonylmethane | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1426694 | glucosamine HCl 750 MG / chondroitin sulfates 150 MG / hyaluronic acid 1 MG / methylsulfonylmethane 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1426694 | glucosamine HCl 750 MG / chondroitin sulfates 150 MG / hyaluronic acid 1 MG / methylsulfonylmethane 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1426700 | potassium sulfooleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426701 | sulfooleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426702 | polyethylene oxide 300000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426702 | polyethylene oxide 300000 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426703 | succinimidyl-4-(n-maleimidomethyl)cyclohexane-1-carboxylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426703 | succinimidyl-4-(n-maleimidomethyl)cyclohexane-1-carboxylate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426704 | neurotrophin 4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426746 | gallic acid monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426747 | polyglyceryl-10 laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426748 | Metaiodobenzylguanidine (123-I) | Designated preferred name (PT) | YES | |
RxCUI: 1426748 | Metaiodobenzylguanidine (123-I) | Full form of descriptor (FN) | YES | |
RxCUI: 1426748 | Metaiodobenzylguanidine (123-I) | Designated preferred name (PT) | YES | |
RxCUI: 1426748 | Metaiodobenzylguanidine (123-I) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426748 | Metaiodobenzylguanidine (123-I) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426748 | Metaiodobenzylguanidine (123-I) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426748 | Metaiodobenzylguanidine (123-I) | Full form of descriptor (FN) | YES | |
RxCUI: 1426763 | APAP 32 MG/ML / Dextromethorphan Hydrobromide 1.5 MG/ML / Pseudoephedrine Hydrochloride 3 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1426763 | APAP 32 MG/ML / Dextromethorphan Hydrobromide 1.5 MG/ML / Pseudoephedrine Hydrochloride 3 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426773 | bis(1-piperidylthiocarbonyl)disulfide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426773 | bis(1-piperidylthiocarbonyl)disulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426773 | bis(1-piperidylthiocarbonyl)disulfide | Designated preferred name (PT) | NO | |
RxCUI: 1426773 | bis(1-piperidylthiocarbonyl)disulfide | Full form of descriptor (FN) | NO | |
RxCUI: 1426773 | bis(1-piperidylthiocarbonyl)disulfide | Designated preferred name (PT) | NO | |
RxCUI: 1426773 | bis(1-piperidylthiocarbonyl)disulfide | Full form of descriptor (FN) | NO | |
RxCUI: 1426777 | limonene, (-)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426778 | phenylmercuric acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426779 | phenylmercury | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426780 | PEG-PPG-20-6 dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426781 | diethylhexyl sebacate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426782 | Ulva compressa extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426783 | pantolactone, (+-)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426813 | Trimethylolpropane triacrylate | Full form of descriptor (FN) | YES | |
RxCUI: 1426813 | Trimethylolpropane triacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426813 | Trimethylolpropane triacrylate | Designated preferred name (PT) | YES | |
RxCUI: 1426813 | Trimethylolpropane triacrylate | Full form of descriptor (FN) | YES | |
RxCUI: 1426813 | Trimethylolpropane triacrylate | Designated preferred name (PT) | YES | |
RxCUI: 1426816 | dextrates | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426817 | phenylephrine hydrochloride 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1426818 | dextromethorphan hydrobromide 20 MG / guaifenesin 380 MG / phenylephrine hydrochloride 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1426818 | dextromethorphan hydrobromide 20 MG / guaifenesin 380 MG / phenylephrine hydrochloride 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1426822 | Imodium Multi-Symptom Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1426823 | loperamide hydrochloride 2 MG / simethicone 125 MG [Imodium Multi-Symptom Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1426824 | loperamide / simethicone Oral Tablet [Imodium Multi-Symptom Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1426825 | Imodium Multi-Symptom Relief Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1426826 | Imodium Multi-Symptom Relief Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1426827 | Imodium Multi-Symptom Relief 2 MG / 125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426827 | Imodium Multi-Symptom Relief 2 MG / 125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1426827 | Imodium Multi-Symptom Relief 2 MG / 125 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1426828 | dimethicone PEG-15 acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426829 | sodium cocoamphoacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426830 | cocoamphoacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426831 | trimethylpentanediol-adipic acid-glycerin crosspolymer (25000 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426837 | Handclens | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1426838 | benzalkonium chloride 1.3 MG/ML [Handclens] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1426839 | benzalkonium Topical Foam [Handclens] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1426840 | Handclens Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1426841 | HandClens 0.13 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1426841 | HandClens 0.13 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426841 | HandClens 0.13 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426841 | HandClens 0.13 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426842 | immunoglobulin A, human | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426843 | menthol 5.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1426844 | menthol 5.3 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426844 | menthol 5.3 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1426846 | hypromellose 2906 (4 mpa.s) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426853 | Mn 2+ | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426853 | Mn 2+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426854 | isoamyl p-methoxycinnamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426854 | isoamyl p-methoxycinnamate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426855 | collagen type I, bovine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426856 | Collagen type I | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426856 | Collagen type I | Designated preferred name (PT) | NO | |
RxCUI: 1426856 | Collagen type I | Full form of descriptor (FN) | NO | |
RxCUI: 1426857 | glyoxal trimer, dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426858 | glyoxal trimer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426861 | GentaVed 0.057 % / 0.0284 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1426861 | GentaVed 0.057 % / 0.0284 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426861 | GentaVed 0.057 % / 0.0284 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426862 | ethylhexyl oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426863 | coconut alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426864 | lysozyme, chicken egg white | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426865 | lysozyme | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426866 | Monocyte derived neutrophil chemotactic factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426866 | Monocyte derived neutrophil chemotactic factor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426866 | Monocyte derived neutrophil chemotactic factor | Designated preferred name (PT) | NO | |
RxCUI: 1426866 | Monocyte derived neutrophil chemotactic factor | Full form of descriptor (FN) | NO | |
RxCUI: 1426866 | Monocyte derived neutrophil chemotactic factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426866 | Monocyte derived neutrophil chemotactic factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426866 | Monocyte derived neutrophil chemotactic factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426866 | Monocyte derived neutrophil chemotactic factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426867 | niobium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426868 | pivalic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426869 | hydrobromic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426870 | Moschus moschiferus musk sac resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426871 | Hexaminolevulinate hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426871 | Hexaminolevulinate hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 1426871 | Hexaminolevulinate hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 1426872 | hexaminolevulinate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426872 | hexaminolevulinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426873 | Hekla lava | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426874 | iodine ioflupane | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426874 | iodine ioflupane | Designated preferred name (PT) | YES | |
RxCUI: 1426874 | iodine ioflupane | Full form of descriptor (FN) | YES | |
RxCUI: 1426874 | iodine ioflupane | Designated preferred name (PT) | YES | |
RxCUI: 1426874 | iodine ioflupane | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426874 | iodine ioflupane | Full form of descriptor (FN) | YES | |
RxCUI: 1426875 | Acemannan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426875 | Acemannan | Designated preferred name (PT) | NO | |
RxCUI: 1426875 | Acemannan | Full form of descriptor (FN) | NO | |
RxCUI: 1426876 | My Way | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1426877 | levonorgestrel 1.5 MG [My Way] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1426878 | levonorgestrel Oral Tablet [My Way] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1426879 | My Way Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1426880 | My Way Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1426881 | My Way Emergency Contraceptive 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1426881 | My Way Emergency Contraceptive 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426881 | My Way Emergency Contraceptive 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1426882 | Borrelia burgdorferi | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426883 | cobaltous chloride hexahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426884 | Cobalt chloride | Designated preferred name (PT) | NO | |
RxCUI: 1426884 | Cobalt chloride | Full form of descriptor (FN) | NO | |
RxCUI: 1426884 | Cobalt chloride | Designated preferred name (PT) | NO | |
RxCUI: 1426884 | Cobalt chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426884 | Cobalt chloride | Full form of descriptor (FN) | NO | |
RxCUI: 1426885 | Carrageen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426885 | Carrageen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426886 | Mercaptamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426886 | Mercaptamine hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 1426886 | Mercaptamine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426886 | Mercaptamine hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 1426887 | Hygromycin B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426887 | Hygromycin B | Designated preferred name (PT) | NO | |
RxCUI: 1426887 | Hygromycin B | Full form of descriptor (FN) | NO | |
RxCUI: 1426888 | meksamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426888 | meksamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426889 | indigo | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426890 | Prl - Prolactin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426890 | Prl - Prolactin | Full form of descriptor (FN) | NO | |
RxCUI: 1426890 | Prl - Prolactin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426890 | Prl - Prolactin | Designated preferred name (PT) | NO | |
RxCUI: 1426890 | Prl - Prolactin | Full form of descriptor (FN) | NO | |
RxCUI: 1426890 | Prl - Prolactin | Designated preferred name (PT) | NO | |
RxCUI: 1426891 | polidronium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426892 | polidronium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426894 | potassium arsenite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426895 | potassium arsenite anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426897 | quaternium-22 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426898 | quinine arsenite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426898 | quinine arsenite | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1426899 | quinine salicylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426899 | quinine salicylate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1426900 | silk, base hydrolyzed (1000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426901 | decylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426902 | Dihydro-alpha-ergocryptine mesilate | British preferred term (PTGB) | YES | |
RxCUI: 1426902 | Dihydro-alpha-ergocryptine mesilate | Full form of descriptor (FN) | YES | |
RxCUI: 1426902 | Dihydro-alpha-ergocryptine mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426902 | Dihydro-alpha-ergocryptine mesilate | Designated preferred name (PT) | YES | |
RxCUI: 1426903 | 2-(2-hydroxy-5-methylphenyl)benzotriazole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426903 | 2-(2-hydroxy-5-methylphenyl)benzotriazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426903 | 2-(2-hydroxy-5-methylphenyl)benzotriazole | Designated preferred name (PT) | NO | |
RxCUI: 1426903 | 2-(2-hydroxy-5-methylphenyl)benzotriazole | Full form of descriptor (FN) | NO | |
RxCUI: 1426903 | 2-(2-hydroxy-5-methylphenyl)benzotriazole | Designated preferred name (PT) | NO | |
RxCUI: 1426903 | 2-(2-hydroxy-5-methylphenyl)benzotriazole | Full form of descriptor (FN) | NO | |
RxCUI: 1426905 | Dihydro-beta-ergocryptine mesilate | British preferred term (PTGB) | YES | |
RxCUI: 1426905 | Dihydro-beta-ergocryptine mesilate | Full form of descriptor (FN) | YES | |
RxCUI: 1426905 | Dihydro-beta-ergocryptine mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426905 | Dihydro-beta-ergocryptine mesilate | Designated preferred name (PT) | YES | |
RxCUI: 1426906 | glucuronic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426907 | glucuronate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426908 | Capsosiphon fulvescens extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426909 | diisopropyl dilinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426910 | Glycogen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426910 | Glycogen | Designated preferred name (PT) | NO | |
RxCUI: 1426910 | Glycogen | Full form of descriptor (FN) | NO | |
RxCUI: 1426911 | mumps virus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426912 | pea extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426912 | pea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426913 | perillaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426914 | polyquaternium-28 (1100000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426915 | glyceryl 1,2-dioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426916 | Trichinella spiralis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426917 | Porphyra yezoensis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426918 | Pseudevernia furfuracea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426919 | Bay oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426919 | Bay oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426919 | Bay oil | Designated preferred name (PT) | NO | |
RxCUI: 1426919 | Bay oil | Full form of descriptor (FN) | NO | |
RxCUI: 1426920 | Sargassum filipendula extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426921 | lentil seed allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426921 | lentil seed allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426922 | lauryl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426923 | Mentha pulegium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426924 | D&C violet no. 2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426925 | glyceryl 1-adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426926 | D.C. red no. 36 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426927 | glyceryl abietate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426928 | glyceryl palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426929 | homarine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426930 | homarine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426931 | ursolic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426932 | distearoylphosphatidylcholine, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1426933 | 1,2-distearoyl-sn-glycero-3-phosphocholine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426933 | 1,2-distearoyl-sn-glycero-3-phosphocholine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426934 | sclareolide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426935 | peg-10 glyceryl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426936 | potassium oleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426937 | lauryl aminopropylglycine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426938 | tetraarsenic tetrasulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426939 | PEG-PPG-20-15 dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426940 | potassium mercuric iodide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426941 | Mercuric iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426941 | Mercuric iodide | Designated preferred name (PT) | NO | |
RxCUI: 1426941 | Mercuric iodide | Full form of descriptor (FN) | NO | |
RxCUI: 1426942 | Bis (dibutyldithiocarbamato) zinc | Designated preferred name (PT) | NO | |
RxCUI: 1426942 | Bis (dibutyldithiocarbamato) zinc | Full form of descriptor (FN) | NO | |
RxCUI: 1426942 | Bis (dibutyldithiocarbamato) zinc | Designated preferred name (PT) | NO | |
RxCUI: 1426942 | Bis (dibutyldithiocarbamato) zinc | Full form of descriptor (FN) | NO | |
RxCUI: 1426942 | Bis (dibutyldithiocarbamato) zinc | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426943 | dibutyldithiocarbamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426944 | glycereth-18 ethylhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426945 | PPG-15 stearyl ether benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426946 | PPG-11 stearyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426947 | PEG-PPG-30-160 copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426948 | trimethylsiloxysilicate (M-Q 0.66) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1426949 | PEG-PPG-105-5 copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426950 | Barbary fig extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426950 | Barbary fig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1426950 | Barbary fig extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1426951 | proline, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1426990 | camphor 2.5 % / menthol 2.5 % / methyl salicylate 10 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426990 | camphor 2.5 % / menthol 2.5 % / methyl salicylate 10 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426990 | camphor 2.5 % / menthol 2.5 % / methyl salicylate 10 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1426991 | camphor 25 MG/ML / menthol 25 MG/ML / methyl salicylate 100 MG/ML [Valtrum Sport] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1426992 | Valtrum Sport 2.5 % / 2.5 % / 10 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1426992 | Valtrum Sport 2.5 % / 2.5 % / 10 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426992 | Valtrum Sport 2.5 % / 2.5 % / 10 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426992 | Valtrum Sport 2.5 % / 2.5 % / 10 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426993 | Clotrimazoil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1426994 | clotrimazole 10 MG/ML [Clotrimazoil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1426995 | clotrimazole Topical Solution [Clotrimazoil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1426996 | Clotrimazoil Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1426997 | ClotrimazOil 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1426997 | ClotrimazOil 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426997 | ClotrimazOil 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1426997 | ClotrimazOil 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1426998 | Lidostat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1426999 | lidocaine hydrochloride 40 MG/ML [Lidostat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1427000 | lidocaine Topical Cream [Lidostat] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1427001 | Lidostat Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1427002 | Lidostat 4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1427002 | Lidostat 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427002 | Lidostat 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427002 | Lidostat 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427003 | camphor 0.045 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1427004 | menthol 0.37 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1427005 | camphor 4.5 % / menthol 37 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1427005 | camphor 4.5 % / menthol 37 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427005 | camphor 4.5 % / menthol 37 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427006 | camphor 0.045 MG/MG / menthol 0.37 MG/MG [Mata Balm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1427007 | mata balm 4.5 % / 37 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1427007 | mata balm 4.5 % / 37 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427007 | mata balm 4.5 % / 37 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427008 | propylene glycol diacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427009 | propylene glycol dicaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427010 | propylene glycol monopalmitostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427011 | propylheptyl caprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427014 | Sometribove | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427014 | Sometribove | Designated preferred name (PT) | NO | |
RxCUI: 1427014 | Sometribove | Full form of descriptor (FN) | NO | |
RxCUI: 1427015 | rice germ preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427016 | PEG-3 distearoylamidoethylmonium methosulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427017 | hexyldecyl myristoyl methylaminopropionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427018 | Pancreatic lipase | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427018 | Pancreatic lipase | Designated preferred name (PT) | YES | |
RxCUI: 1427018 | Pancreatic lipase | Full form of descriptor (FN) | YES | |
RxCUI: 1427033 | pancrelipase amylase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427034 | pancrelipase protease | Designated preferred name (PT) | YES | |
RxCUI: 1427034 | pancrelipase protease | Full form of descriptor (FN) | YES | |
RxCUI: 1427034 | pancrelipase protease | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427042 | sucrose stearate-palmitate ester (75% mono ester) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427043 | PEG-PPG-36-41 dimethyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427044 | Penicillium digitatum allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427045 | ethylene-vinyl acetate copolymer (9% vinyl acetate) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427046 | Triticum vulgare extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427046 | Triticum vulgare extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427047 | dimyristoylphosphatidylglycerol, DL | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427048 | dimyristoylphosphatidylglycerol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427050 | dimyristoylphosphatidylcholine, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427053 | malic acid, L- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427054 | cerous oxalate nonahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427055 | cupric carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427055 | cupric carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427056 | potato starch | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427057 | oxalic acid, dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427058 | oxalic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427059 | perennial ryegrass allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427059 | perennial ryegrass allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427059 | perennial ryegrass allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427060 | propylene glycol heptanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427061 | ammonium phosphate, dibasic | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427062 | staphylococcus aureus immunoserum, rabbit | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427063 | staphylococcus aureus immunoserum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427064 | acetylated sucrose distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427065 | methyl undecenoyl leucinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427066 | potassium thiocyanate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427067 | thiocyanate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427068 | sebacic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427069 | sebacate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427070 | lauramide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427071 | water, O-15 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427072 | ethyl lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427073 | Glucose oxyhydrase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427073 | Glucose oxyhydrase | Designated preferred name (PT) | YES | |
RxCUI: 1427073 | Glucose oxyhydrase | Full form of descriptor (FN) | YES | |
RxCUI: 1427073 | Glucose oxyhydrase | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427074 | carvone, (+-)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427075 | Carvone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427075 | Carvone | Designated preferred name (PT) | NO | |
RxCUI: 1427075 | Carvone | Full form of descriptor (FN) | NO | |
RxCUI: 1427076 | glyceryl arachidonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427077 | glyceryl ricinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427078 | glycofurol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427079 | glycol dimethacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427080 | wheat middlings extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427082 | laurtrimonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427083 | laurtrimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427084 | 7-keto-dehydroepiandrosterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427084 | 7-keto-dehydroepiandrosterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427085 | pepper extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427086 | avotermin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427087 | phosphorous acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427087 | phosphorous acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427088 | uric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427123 | Arthrospira maxima preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427123 | Arthrospira maxima preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427124 | triisononanoin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427125 | diisocetyl dodecanedioate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427134 | Ustilago maydis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427136 | N-cyclohexyl-N'-phenyl-p-phenylenediamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427136 | N-cyclohexyl-N'-phenyl-p-phenylenediamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427137 | foreskin fibroblast, neonatal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427138 | foreskin keratinocyte, neonatal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427139 | Ophiocordyceps sinensis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427140 | potassium lauryl sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427142 | benzylidene dimethoxydimethylindanone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427143 | caprooyl tetrapeptide-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427148 | PPG-3 myristyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427149 | carbocysteine lysine | British preferred term (PTGB) | NO | |
RxCUI: 1427149 | carbocysteine lysine | Full form of descriptor (FN) | NO | |
RxCUI: 1427149 | carbocysteine lysine | Designated preferred name (PT) | NO | |
RxCUI: 1427149 | carbocysteine lysine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427149 | carbocysteine lysine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427150 | glyceryl 1,2-dibehenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427150 | glyceryl 1,2-dibehenate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427153 | germanium citrate lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427157 | epidermal growth factor, human | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427157 | epidermal growth factor, human | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427157 | epidermal growth factor, human | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427158 | Anthelone U | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427158 | Anthelone U | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427158 | Anthelone U | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427158 | Anthelone U | Designated preferred name (PT) | NO | |
RxCUI: 1427158 | Anthelone U | Full form of descriptor (FN) | NO | |
RxCUI: 1427158 | Anthelone U | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427163 | interleukin-6, human | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427168 | ling preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427171 | hepatitis B virus subtype ADW2 HBsAg surface protein antigen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427172 | L-lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427173 | glyceryl 1-stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427179 | Antithrombin alfa | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427179 | Antithrombin alfa | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427179 | Antithrombin alfa | Full form of descriptor (FN) | YES | |
RxCUI: 1427179 | Antithrombin alfa | Designated preferred name (PT) | YES | |
RxCUI: 1427179 | Antithrombin alfa | Full form of descriptor (FN) | YES | |
RxCUI: 1427179 | Antithrombin alfa | Designated preferred name (PT) | YES | |
RxCUI: 1427180 | gentisic acid ethanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427184 | octadecenedioic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427185 | octadecenedioate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427186 | lauryl PEG-PPG-18-18 methicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427188 | hydroxyphenyl propamidobenzoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427189 | p-tert-butylphenol-formaldehyde resin (low molecular weight) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427192 | Zinc diethyldithiocarbamate | Designated preferred name (PT) | NO | |
RxCUI: 1427192 | Zinc diethyldithiocarbamate | Full form of descriptor (FN) | NO | |
RxCUI: 1427192 | Zinc diethyldithiocarbamate | Designated preferred name (PT) | NO | |
RxCUI: 1427192 | Zinc diethyldithiocarbamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427192 | Zinc diethyldithiocarbamate | Full form of descriptor (FN) | NO | |
RxCUI: 1427192 | Zinc diethyldithiocarbamate | Full form of descriptor (FN) | NO | |
RxCUI: 1427192 | Zinc diethyldithiocarbamate | Designated preferred name (PT) | NO | |
RxCUI: 1427192 | Zinc diethyldithiocarbamate | Full form of descriptor (FN) | NO | |
RxCUI: 1427192 | Zinc diethyldithiocarbamate | Designated preferred name (PT) | NO | |
RxCUI: 1427193 | diethyldithiocarbamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427195 | egg shell, cooked | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427196 | dodecyl-2-N,N-dimethylaminopropionate hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427197 | dodecyl-2-N,N-dimethylaminopropionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427198 | Cu 2+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427198 | Cu 2+ | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427199 | potassium ascorbyl tocopheryl phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427200 | ascorbyl tocopheryl phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427201 | Glycoprotein hormone alpha subunit | Designated preferred name (PT) | NO | |
RxCUI: 1427201 | Glycoprotein hormone alpha subunit | Full form of descriptor (FN) | NO | |
RxCUI: 1427201 | Glycoprotein hormone alpha subunit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427201 | Glycoprotein hormone alpha subunit | Designated preferred name (PT) | NO | |
RxCUI: 1427201 | Glycoprotein hormone alpha subunit | Full form of descriptor (FN) | NO | |
RxCUI: 1427202 | lauryl pidolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427202 | lauryl pidolate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427203 | Sodium aluminosilicate | British preferred term (PTGB) | YES | |
RxCUI: 1427203 | Sodium aluminosilicate | Full form of descriptor (FN) | YES | |
RxCUI: 1427203 | Sodium aluminosilicate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427203 | Sodium aluminosilicate | Designated preferred name (PT) | YES | |
RxCUI: 1427203 | Sodium aluminosilicate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427203 | Sodium aluminosilicate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
RxCUI: 1427203 | Sodium aluminosilicate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427203 | Sodium aluminosilicate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427203 | Sodium aluminosilicate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427206 | Lachnanthes caroliniana extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427207 | synthetic wax (1900 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427208 | ovemotide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427209 | human coxsackievirus B1 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427210 | human coxsackievirus B4 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427211 | hepatitis B virus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427212 | poliovirus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427215 | amodimethicone (800 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427216 | psorinum lesion lysate (human) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427216 | psorinum lesion lysate (human) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427217 | methyl dihydrojasmonate (synthetic) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427218 | methylsilanol acetylmethionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427219 | methylbenzyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427220 | Cyberlindnera jadinii extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427220 | Cyberlindnera jadinii extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427221 | sardine, unspecified preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427222 | Parathormone | Full form of descriptor (FN) | YES | |
RxCUI: 1427222 | Parathormone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427222 | Parathormone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427222 | Parathormone | Designated preferred name (PT) | YES | |
RxCUI: 1427222 | Parathormone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427223 | iobenguane sulfate I-123 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427224 | florbetapir (18F) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427224 | florbetapir (18F) | Designated preferred name (PT) | YES | |
RxCUI: 1427224 | florbetapir (18F) | Full form of descriptor (FN) | YES | |
RxCUI: 1427224 | florbetapir (18F) | Designated preferred name (PT) | YES | |
RxCUI: 1427224 | florbetapir (18F) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427224 | florbetapir (18F) | Full form of descriptor (FN) | YES | |
RxCUI: 1427225 | florbetapir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427226 | isopropyl lauroyl sarcosinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427227 | PPG-1 trideceth-6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427228 | poly(methyl acrylate-co-methyl methacrylate-co-methacrylic acid 7:3:1; 280000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427229 | hydrolysed marine collagen (enzymatic; 2000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427230 | N,N-bis(2-hydroxyethyl)-p-phenylenediamine sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427231 | ceteth-23 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427232 | quinic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427233 | quinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427235 | alpha-tocopherol linoleate, D- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1427236 | pantolactone, (R)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1427237 | pantolactone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427238 | mecetronium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1427238 | mecetronium bromide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427294 | Repara Triple Antibiotic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1427295 | bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG [Repara Triple Antibiotic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1427296 | bacitracin / neomycin / polymyxin B Topical Ointment [Repara Triple Antibiotic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1427297 | Repara Triple Antibiotic Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1427298 | REPARA Triple Antibiotic 400 UNT / 3.5 MG / 5000 UNT per GM Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1427298 | REPARA Triple Antibiotic 400 UNT / 3.5 MG / 5000 UNT per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427298 | REPARA Triple Antibiotic 400 UNT / 3.5 MG / 5000 UNT per GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427300 | Pirmella 1/35 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1427300 | Pirmella 1/35 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1427300 | Pirmella 1/35 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427301 | Pirmella 7/7/7 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1427301 | Pirmella 7/7/7 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1427301 | Pirmella 7/7/7 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427375 | Abridge Maximum Strength Cold Sore | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1427376 | benzalkonium chloride 1.3 MG/ML / camphor 30 MG/ML [Abridge Maximum Strength Cold Sore] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1427377 | benzalkonium / camphor Topical Cream [Abridge Maximum Strength Cold Sore] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1427378 | Abridge Maximum Strength Cold Sore Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1427379 | Abridge Maximum Strength Cold Sore (benzalkonium chloride 0.13 % / camphor 3 % ) Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427379 | Abridge Maximum Strength Cold Sore (benzalkonium chloride 0.13 % / camphor 3 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427379 | Abridge Maximum Strength Cold Sore (benzalkonium chloride 0.13 % / camphor 3 % ) Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1427387 | thonzylamine hydrochloride 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1427388 | dextromethorphan / phenylephrine / thonzylamine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1427389 | dextromethorphan / phenylephrine / thonzylamine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1427390 | dextromethorphan / phenylephrine / thonzylamine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1427391 | dextromethorphan / phenylephrine / thonzylamine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1427392 | dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / thonzylamine HCl 25 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1427392 | dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / thonzylamine HCl 25 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427392 | dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / thonzylamine HCl 25 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1427393 | levothyroxine sodium 0.1 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427393 | levothyroxine sodium 0.1 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1427394 | levothyroxine sodium 0.9 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1427395 | levothyroxine sodium 0.9 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427395 | levothyroxine sodium 0.9 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1427396 | levothyroxine sodium 1 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427396 | levothyroxine sodium 1 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1427405 | Lice-Nil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1427406 | piperonyl butoxide 40 MG/ML / pyrethrins 3.3 MG/ML [Lice-Nil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1427407 | piperonyl butoxide / pyrethrins Medicated Shampoo [Lice-Nil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1427408 | Lice-Nil Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1427409 | Lice-Nil 4 % / 0.33 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427409 | Lice-Nil 4 % / 0.33 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427409 | Lice-Nil 4 % / 0.33 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1427410 | zinc oxide 1.8 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1427410 | zinc oxide 1.8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427410 | zinc oxide 1.8 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1427410 | zinc oxide 1.8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427411 | butylene glycol dicaprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427412 | dipentaerythrityl hexa C5-10 acid esters | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1427413 | lingonberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 14278 | Carboxy-cis,cis-muconate cyclase | Designated preferred name (PT) | NO | |
RxCUI: 14278 | Carboxy-cis,cis-muconate cyclase | Full form of descriptor (FN) | NO | |
RxCUI: 14279 | 3-carboxy-cis,cis-muconate cycloisomerase | Designated preferred name (PT) | NO | |
RxCUI: 14279 | 3-carboxy-cis,cis-muconate cycloisomerase | Full form of descriptor (FN) | NO | |
RxCUI: 1427953 | petrolatum 490 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1427954 | petrolatum 49 % / zinc oxide 15 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1427954 | petrolatum 49 % / zinc oxide 15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427954 | petrolatum 49 % / zinc oxide 15 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1427954 | petrolatum 49 % / zinc oxide 15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1427955 | Welmedix Homecare Pro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1427956 | petrolatum 490 MG/ML / zinc oxide 150 MG/ML [Welmedix Homecare Pro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1427957 | petrolatum / zinc oxide Topical Cream [Welmedix Homecare Pro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1427958 | Welmedix Homecare Pro Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1427959 | Welmedix Homecare Pro (petrolatum 49 % / zinc oxide 15 % ) Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1427959 | Welmedix Homecare Pro (petrolatum 49 % / zinc oxide 15 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427959 | Welmedix Homecare Pro (petrolatum 49 % / zinc oxide 15 % ) Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427959 | Welmedix Homecare Pro (petrolatum 49 % / zinc oxide 15 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427961 | Welmedix Homecare Pro Fragile Skin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1427962 | petrolatum 0.42 MG/MG [Welmedix Homecare Pro Fragile Skin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1427963 | petrolatum Topical Ointment [Welmedix Homecare Pro Fragile Skin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1427964 | Welmedix Homecare Pro Fragile Skin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1427965 | Welmedix HomeCare PRO Fragile Skin Protectant 42 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1427965 | Welmedix HomeCare PRO Fragile Skin Protectant 42 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427965 | Welmedix HomeCare PRO Fragile Skin Protectant 42 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427965 | Welmedix HomeCare PRO Fragile Skin Protectant 42 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427980 | Welmedix Homecare Pro 2-in-1 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1427981 | miconazole nitrate 0.02 MG/MG [Welmedix Homecare Pro 2-in-1] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1427982 | miconazole Topical Ointment [Welmedix Homecare Pro 2-in-1] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1427983 | Welmedix Homecare Pro 2-in-1 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1427984 | Welmedix HomeCare PRO 2-in-1 Antifungal & Skin Protectant 2 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1427984 | Welmedix HomeCare PRO 2-in-1 Antifungal & Skin Protectant 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427984 | Welmedix HomeCare PRO 2-in-1 Antifungal & Skin Protectant 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427984 | Welmedix HomeCare PRO 2-in-1 Antifungal & Skin Protectant 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427993 | Clearasil Toner | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1427994 | salicylic acid 10 MG/ML [Clearasil Toner] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1427995 | salicylic acid Topical Solution [Clearasil Toner] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1427996 | Clearasil Toner Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1427997 | Clearasil Toner 1 % Topical solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1427997 | Clearasil Toner 1 % Topical solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427997 | Clearasil Toner 1 % Topical solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1427997 | Clearasil Toner 1 % Topical solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1427998 | dextromethorphan HBr 20 MG / guaiFENesin 380 MG / pseudoephedrine HCl 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1427998 | dextromethorphan HBr 20 MG / guaiFENesin 380 MG / pseudoephedrine HCl 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1427998 | dextromethorphan HBr 20 MG / guaiFENesin 380 MG / pseudoephedrine HCl 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1428024 | lactate Topical Cream [Geri-Hydrolac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1428025 | Geri-Hydrolac (ammonium lactate 12 % ) Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1428025 | Geri-Hydrolac (ammonium lactate 12 % ) Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1428025 | Geri-Hydrolac (ammonium lactate 12 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1428025 | Geri-Hydrolac (ammonium lactate 12 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1428027 | Calendula officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1428039 | calenduloside E | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1428041 | polyquaternium-39 (22.5-51-26.5 acrylic acid-acrylamide-DADMAC; 1600000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1428042 | Panax quinquefolius whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428043 | Hyacinthoides non-scripta extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428044 | egg shell membrane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1428133 | thonzylamine hydrochloride 6.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1428134 | chlophedianol / thonzylamine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1428135 | chlophedianol / thonzylamine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1428136 | chlophedianol / thonzylamine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1428137 | chlophedianol / thonzylamine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1428138 | chlophedianol HCl 6.25 MG / thonzylamine HCl 6.25 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1428138 | chlophedianol HCl 6.25 MG / thonzylamine HCl 6.25 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428138 | chlophedianol HCl 6.25 MG / thonzylamine HCl 6.25 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1428214 | Alisma plantago-aquatica top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428215 | polyquaternium-10 (30000 MPA.S at 2%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1428216 | Chenopodium vulvaria extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428217 | cupric glycinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428218 | Erechtites hieraciifolius extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428219 | Euonymus atropurpureus branch bark-root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428412 | Althaea officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428413 | calcium hydride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1428414 | Agrostemma githago seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428415 | Alnus serrulata bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428416 | Asarum canadense root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428417 | Cynodon dactylon extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428418 | Fraxinus americana bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428420 | Jacobaea vulgaris whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428420 | Jacobaea vulgaris whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1428421 | Platanus x acerifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428422 | Populus balsamifera leaf bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1428423 | Sassafra albidum root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428547 | HDI - 1,6-Hexamethylene di-isocyanate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428547 | HDI - 1,6-Hexamethylene di-isocyanate | Designated preferred name (PT) | NO | |
RxCUI: 1428547 | HDI - 1,6-Hexamethylene di-isocyanate | Full form of descriptor (FN) | NO | |
RxCUI: 1428547 | HDI - 1,6-Hexamethylene di-isocyanate | Designated preferred name (PT) | NO | |
RxCUI: 1428547 | HDI - 1,6-Hexamethylene di-isocyanate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1428547 | HDI - 1,6-Hexamethylene di-isocyanate | Full form of descriptor (FN) | NO | |
RxCUI: 1428621 | acetaminophen 300 MG / butalbital 50 MG [Bupap] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1428622 | BUPAP 50 MG / 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1428622 | BUPAP 50 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428622 | BUPAP 50 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428622 | BUPAP 50 MG / 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1428825 | MVC-Fluoride Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1428826 | MVC-Fluoride Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1428827 | MVC-Fluoride Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428828 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT Chewable Tablet [MVC-Fluoride] | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428830 | Baciguent 500 UNT/GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1428830 | Baciguent 500 UNT/GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1428830 | Baciguent 500 UNT/GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1428830 | Baciguent 500 UNT/GM Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1428832 | 2-(L-menthoxy)ethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428833 | benzophenone-5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1428835 | ferric hydroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428837 | Melia azedarach bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428838 | Melia azedarach fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428840 | Psidium guajava extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428841 | Morus australis wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428842 | Vigna radiata extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428843 | Orris root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428843 | Orris root extract | Designated preferred name (PT) | NO | |
RxCUI: 1428843 | Orris root extract | Full form of descriptor (FN) | NO | |
RxCUI: 1428843 | Orris root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1428844 | Dianthus caryophyllus flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428845 | Ficus carica flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428846 | garden snail mucin preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428847 | Cucumis melo extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428848 | Adansonia digitata leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428849 | Adansonia digitata seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428851 | Monarda didyma leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428852 | Nelumbo nucifera germ extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428853 | Curcuma longa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1428854 | apricot fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428855 | desert date extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428856 | trehalulose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428857 | tris-BHT mesitylene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428858 | tetradecamethylhexasiloxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428859 | 2-ethyl-1,6-hexanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428860 | azelamide monoethanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428861 | basic yellow 57 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428862 | butylene glycol dicaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428863 | C10-36 olefin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428864 | caprylyl trimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428865 | ceteth-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428866 | Daucus carota subsp. sativus extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428866 | Daucus carota subsp. sativus extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1428867 | diethadione | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428868 | disodium HEDTA | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1428869 | diethyl sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428870 | glycol cetearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428871 | astaxanthin 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1428872 | astaxanthin 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1428872 | astaxanthin 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1428873 | HC yellow no. 5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1428874 | lauryl glycol hydroxypropyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428875 | PEG-32 oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428876 | Petasites fragrans extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428877 | PPG-10 methyl glucose ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428878 | D-glutamic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1428880 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Packets for Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Packets for Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 1428880 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Packets for Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Packets for Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1428880 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Packets for Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Packets for Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1428880 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Packets for Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Packets for Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428880 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Packets for Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Packets for Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1428922 | glucomannan 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1428923 | glucomannan 1000 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1428923 | glucomannan 1000 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1428926 | triprolidine hydrochloride 0.625 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1428927 | triprolidine HCl 0.625 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1428927 | triprolidine HCl 0.625 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428927 | triprolidine HCl 0.625 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1428927 | triprolidine HCl 0.625 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428929 | calcium phosphate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1428930 | calcium phosphate / cholecalciferol Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1428931 | calcium phosphate / cholecalciferol Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1428933 | Orsythia 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1428933 | Orsythia 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1428933 | Orsythia 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428940 | inulin 833 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1428941 | inulin Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1428942 | inulin 833.25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1428942 | inulin 833.25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1428942 | inulin 833.25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1428946 | lenalidomide 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1428947 | lenalidomide 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1428947 | lenalidomide 20 MG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 1428947 | lenalidomide 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1428947 | lenalidomide 20 MG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 1428948 | lidocaine 4 % / menthol 4 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1428948 | lidocaine 4 % / menthol 4 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1428948 | lidocaine 4 % / menthol 4 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428949 | alpha hydroxy acids 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1428950 | alpha hydroxy acids / urea Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1428951 | alpha hydroxy acids / urea Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1428952 | alpha hydroxy acids / urea | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1428953 | urea 25 % / alpha hydroxy acids 6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1428953 | urea 25 % / alpha hydroxy acids 6 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1428953 | urea 25 % / alpha hydroxy acids 6 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1428954 | Hydrasyn25 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1428955 | alpha hydroxy acids 60 MG/ML / urea 250 MG/ML [Hydrasyn25] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1428956 | alpha hydroxy acids / urea Topical Cream [Hydrasyn25] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1428957 | Hydrasyn25 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1428958 | alpha hydroxy acids 60 MG/ML / urea 250 MG/ML Topical Cream [Hydrasyn25] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1428958 | alpha hydroxy acids 60 MG/ML / urea 250 MG/ML Topical Cream [Hydrasyn25] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1428996 | Aspirin, buffered | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1428996 | Aspirin, buffered | Designated preferred name (PT) | NO | |
RxCUI: 1428996 | Aspirin, buffered | Full form of descriptor (FN) | NO | |
RxCUI: 1428996 | Aspirin, buffered | Designated preferred name (PT) | NO | |
RxCUI: 1428996 | Aspirin, buffered | Full form of descriptor (FN) | NO | |
RxCUI: 1429018 | menthol 1.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1429019 | menthol 1.8 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1429019 | menthol 1.8 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1429028 | AmproMed for Calves | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1429029 | amprolium 96 MG/ML [AmproMed for Calves] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1429030 | amprolium Oral Solution [AmproMed for Calves] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1429031 | AmproMed for Calves Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1429032 | AmproMed for Calves Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1429033 | amprolium 96 MG/ML Oral Solution [AmproMed for Calves] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1429033 | amprolium 96 MG/ML Oral Solution [AmproMed for Calves] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429033 | amprolium 96 MG/ML Oral Solution [AmproMed for Calves] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429042 | Portulaca oleracea leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429043 | bis-hydroxyethoxypropyl dimethicone (37 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429044 | Ibuprofen sodium | Designated preferred name (PT) | YES | |
RxCUI: 1429044 | Ibuprofen sodium | Full form of descriptor (FN) | YES | |
RxCUI: 1429044 | Ibuprofen sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1429278 | Bloxiverz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1429280 | neostigmine Injectable Solution [Bloxiverz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1429281 | Bloxiverz Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1429282 | Bloxiverz 0.5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1429282 | Bloxiverz 0.5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1429282 | Bloxiverz 0.5 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1429284 | Bloxiverz 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1429284 | Bloxiverz 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1429284 | Bloxiverz 1 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1429287 | calcium phosphate 200 MG / cholecalciferol 200 UNT Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1429287 | calcium phosphate 200 MG / cholecalciferol 200 UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1429334 | Tree pollen | Designated preferred name (PT) | NO | |
RxCUI: 1429334 | Tree pollen | Full form of descriptor (FN) | NO | |
RxCUI: 1429345 | chlorpheniramine maleate 1 MG / phenylephrine hydrochloride 2.5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1429345 | chlorpheniramine maleate 1 MG / phenylephrine hydrochloride 2.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1429345 | chlorpheniramine maleate 1 MG / phenylephrine hydrochloride 2.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1429355 | pyrilamine maleate 3.33 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1429356 | chlophedianol / pyrilamine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1429357 | chlophedianol / pyrilamine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1429358 | chlophedianol / pyrilamine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1429359 | chlophedianol / pyrilamine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1429360 | chlophedianol HCl 25 MG / pyrilamine maleate 50 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1429360 | chlophedianol HCl 25 MG / pyrilamine maleate 50 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1429360 | chlophedianol HCl 25 MG / pyrilamine maleate 50 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429361 | dextromethorphan hydrobromide 1.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1429362 | dextromethorphan HBr 18 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1429362 | dextromethorphan HBr 18 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1429362 | dextromethorphan HBr 18 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1429362 | dextromethorphan HBr 18 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1429362 | dextromethorphan HBr 18 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1429366 | lenalidomide 20 MG [Revlimid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1429367 | Revlimid 20 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1429367 | Revlimid 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1429367 | Revlimid 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1429371 | camphor 0.083 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1429372 | menthol 0.0332 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1429373 | methyl salicylate 0.138 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1429374 | camphor 8.3 % / menthol 3.32 % / methyl salicylate 13.84 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1429374 | camphor 8.3 % / menthol 3.32 % / methyl salicylate 13.84 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1429374 | camphor 8.3 % / menthol 3.32 % / methyl salicylate 13.84 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429375 | Rectacort-HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1429376 | hydrocortisone acetate 25 MG [Rectacort-HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1429377 | hydrocortisone Rectal Suppository [Rectacort-HC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1429378 | Rectacort-HC Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1429379 | Rectacort-HC 25 MG Rectal Suppository | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1429379 | Rectacort-HC 25 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1429379 | Rectacort-HC 25 MG Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429380 | Soft-Tuch | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1429381 | bronopol 2 MG/ML [Soft-Tuch] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1429382 | bronopol Topical Solution [Soft-Tuch] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1429383 | Soft-Tuch Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1429384 | SOFT-TUCH 0.2 % Non-Iodine Barrier Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1429384 | SOFT-TUCH 0.2 % Non-Iodine Barrier Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1429384 | SOFT-TUCH 0.2 % Non-Iodine Barrier Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429384 | SOFT-TUCH 0.2 % Non-Iodine Barrier Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429385 | Vita Numonyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1429386 | ergocalciferol 500 UNT/ML / vitamin A 5000 UNT/ML [Vita Numonyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1429387 | ergocalciferol / vitamin A Injectable Solution [Vita Numonyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1429388 | Vita Numonyl Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1429389 | ergocalciferol 500 UNT/ML / vitamin A 5000 UNT/ML Injectable Solution [Vita Numonyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1429389 | ergocalciferol 500 UNT/ML / vitamin A 5000 UNT/ML Injectable Solution [Vita Numonyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429389 | ergocalciferol 500 UNT/ML / vitamin A 5000 UNT/ML Injectable Solution [Vita Numonyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429389 | ergocalciferol 500 UNT/ML / vitamin A 5000 UNT/ML Injectable Solution [Vita Numonyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429389 | ergocalciferol 500 UNT/ML / vitamin A 5000 UNT/ML Injectable Solution [Vita Numonyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429391 | Glechoma longituba top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429392 | Liquidambar formosana resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429394 | Ocimum gratissimum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429395 | polyquaternium-10 (125 MPA.S at 2%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1429403 | Vanacof-8 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1429404 | chlophedianol hydrochloride 1.67 MG/ML / pyrilamine maleate 3.33 MG/ML [Vanacof-8] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1429405 | chlophedianol / pyrilamine Oral Solution [Vanacof-8] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1429407 | Vanacof-8 Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1429408 | Vanacof-8 Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1429409 | Vanacof-8 25 MG / 50 MG in 30 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1429409 | Vanacof-8 25 MG / 50 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429409 | Vanacof-8 25 MG / 50 MG in 30 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1429434 | Vanahist PD | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1429435 | triprolidine hydrochloride 0.625 MG/ML [Vanahist PD] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1429436 | triprolidine Oral Solution [Vanahist PD] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1429437 | Vanahist PD Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1429438 | Vanahist PD Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1429439 | VANAHIST PD 0.625 MG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1429439 | VANAHIST PD 0.625 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1429439 | VANAHIST PD 0.625 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1429469 | metronidazole / spiramycin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1429469 | metronidazole / spiramycin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1429877 | Ampromed-P | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1429878 | amprolium 96 MG/ML [Ampromed-P] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1429879 | amprolium Oral Solution [Ampromed-P] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1429880 | Ampromed-P Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1429881 | Ampromed-P Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1429882 | amprolium 96 MG/ML Oral Solution [Ampromed-P] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1429882 | amprolium 96 MG/ML Oral Solution [Ampromed-P] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429882 | amprolium 96 MG/ML Oral Solution [Ampromed-P] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429883 | Lysol No-Touch Hand Soap | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1429884 | benzalkonium chloride 1 MG/ML [Lysol No-Touch Hand Soap] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1429885 | benzalkonium Medicated Liquid Soap [Lysol No-Touch Hand Soap] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1429886 | Lysol No-Touch Hand Soap Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1429887 | Lysol No-Touch 0.1 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1429887 | Lysol No-Touch 0.1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1429887 | Lysol No-Touch 0.1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429887 | Lysol No-Touch 0.1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429889 | Miracle Foot Repair | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1429890 | menthol 1 MG/ML [Miracle Foot Repair] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1429891 | menthol Topical Cream [Miracle Foot Repair] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1429892 | Miracle Foot Repair Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1429893 | Miracle Foot Repair 0.1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1429893 | Miracle Foot Repair 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1429893 | Miracle Foot Repair 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1429893 | Miracle Foot Repair 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1429914 | acrylic acid-sodium acrylate copolymer (1:1; 600 MPA.S at 0.2%) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1429926 | marijuana seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429926 | marijuana seed extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429927 | Chamaecyparis obtusa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429928 | diethylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429933 | isopropyl isobutyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429934 | Limnanthes alba whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429937 | macadamia seed oil glycereth-8 esters | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1429939 | Melia azedarach whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429943 | methacrylate/methoxy PEG-10 maleate/styrene copolymer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1429943 | methacrylate/methoxy PEG-10 maleate/styrene copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1429947 | Product containing artesunate and mefloquine (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 1429947 | Product containing artesunate and mefloquine (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 1429948 | Polygala tenuifolia root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429953 | Pulsatilla koreana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429963 | Antigen of Brucella | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429963 | Antigen of Brucella | Full form of descriptor (FN) | NO | |
RxCUI: 1429963 | Antigen of Brucella | Designated preferred name (PT) | NO | |
RxCUI: 1429963 | Antigen of Brucella | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1429968 | wine grape juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1429969 | Lonicera caprifolium flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |